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ABSTRACT
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM THROUGHOUT
THE ESTROUS CYCLE AND DURING THE ATTAINMENT OF PUBERTY IN
GILTS
ERIC STEVEN JOLITZ
2016
Kisspeptin has been demonstrated to affect reproductive cyclicity and the
attainment of puberty in multiple species, presumably through its actions on GnRH and
LH, as demonstrated in other species. Kisspeptin administration causes increased plasma
concentrations of LH in pigs, sheep, and rats. Two experiments were conducted to
evaluate 1) the hypothalamic kisspeptin system throughout various days of the estrous
cycle and 2) the hypothalamic kisspeptin system during the peripubertal period in gilts. In
experiment 1, 40 crossbred gilts (191 d, 121 kg) were administered an intramuscular
injection of PG600. Twelve days after the administration of PG600, gilts were fed 15 mg
of altrenogest daily for 15 d to synchronize estrus. Following estrus synchronization,
estrus detection was performed by exposing gilts to a mature boar and the first day gilts
stood immobile was denoted d 1 of the estrous cycle. Blood samples were collected via
jugular venipuncture on d 1, 4, 7, 9, 14, 16, and 19 of the estrous cycle. Ten animals were
slaughtered on d 1, 9, 14, and 21 of the estrous cycle when MBH, AP, and blood were
collected. Relative expression of hypothalamic Kiss1, Kiss1R, ER-, ER- and -actin
was determined using real-time reverse transcriptase PCR. Fold changes in relative
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expression were determined using the Relative Expression Software Tool. Relative
expression of Kiss1 was increased (P=0.006) 3.2 fold on d 1 versus d 21 and (P=0.003)
2.3 fold on d 9 versus d 21 of the estrous cycle. Relative expression of Kiss1 was not
different (P>0.05) among the remaining days. Relative expression of ER- was decreased
(P=0.05) 0.8 fold on d 9 versus d 21 and (P=0.005) 0.7 fold on d 14 versus d 21. Relative
expression of ER- was not different (P>0.05) among the remaining days. Relative
expression of Kiss1R and ER- were each not different (P>0.05) among days. In
experiment 2, two studies were performed, each with 25 crossbred gilts (151 d, 105 kg).
In study 1 gilts were slaughtered on d 7 and in study 2 gilts were slaughtered on d 8. Gilts
were relocated and exposed to a mature boar throughout study to naturally induce
puberty. Gilts that stood immobile within 24 hours of slaughter were considered to have
attained puberty (n=8/study). Plasma samples were collected on d 1, 3, and 7 of the first
study and d 2, 4, 6, and 8 of the second study. When gilts were slaughtered in both
studies, MBH, AP, and blood were collected. Relative expression of MBH Kiss1 and
actin and AP GnRHR, LH-, and actin was determined using real-time reverse
transcriptase PCR. Fold changes in relative expression were determined using the
Relative Expression Software Tool. Hypothalamic and AP content of kisspeptin were
determined by RIA and differences were determined using the GLIMMIX procedure of
SAS. Relative expression of Kiss1 was increased (P=0.005) 2.2 fold in the gilts that had
attained puberty in the first study, however, was not different (P=0.16) when comparing
treatments in the second study. Relative expression of GnRHR was not different (P>0.05)
between treatments in both studies. Relative expression of LH- tended to be decreased
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(P=0.09) 0.80 fold in the first study but was not different (P=0.19) in gilts that attained
puberty in the second study. AP concentrations of LH were not different (P=0.35)
between treatments in the first study and were decreased (P=0.01) in gilts that attained
puberty in the second study. AP concentrations of kisspeptin were not different (P=0.43)
in the first study but were increased (P=0.04) in gilts that had attained puberty in the
second study. MBH concentrations of kisspeptin were increased (P=0.03) in gilts that had
attained puberty in the first study but were not different (P=0.68) between treatments in
the second study. These data further support the notion that MBH expression of Kiss1
and concentrations of kisspeptin and AP concentrations of kisspeptin influence
reproductive cyclycity and the attainment of puberty in the gilt.
Keywords: Kisspeptin; Kisspeptin Receptor; Hypothalamus; Pituitary; Pig
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Chapter 1
Literature Review
Kisspeptin background
Kisspeptin has been demonstrated to play a pivotal role in many physiological
functions, including reproduction and the growth of proliferating cells. First discovered in
1996 in Hershey, PA, the Kisspeptin1 gene (Kiss1) was termed a metastasis-suppressor
gene due to its anti-oncogenic growth characteristics in the human (Lee et al., 1996).
Since 1996, kisspeptin has been extensively demonstrated to also play a major role in
reproduction through its actions on GnRH in a number of mammalian and nonmammalian species (Abbara et al., 2013; Clarkson et al., 2008; Colledge and
d'Anglemont de Tassigny, 2010; Decourt et al., 2008; Elizur, 2009; Franceschini et al.,
2006; Hrabovszky et al., 2007; Seminara et al., 2003; Tobari et al., 2010). Its actions on
GnRH may be of importance during the attainment of puberty, estrous cycle and may
have effects during pregnancy, parturition, lactation, and the postpartum recovery period
in pigs (Caraty et al., 2007; Castellano et al., 2005; Clarkson, 2013).
Past research has indicated that the Kiss1 and the Kiss1-receptor gene (Kiss1R)
are highly expressed throughout many tissues in pigs (Li et al., 2008). Li et al. (2008)
analyzed 18 tissues for the presence of Kiss1R transcripts and found it was particularly
abundant in the adrenal, prostate, testis, thymus, pituitary, and hypothalamus. Because
the Kiss1R is present in so many tissues throughout the body it is likely that kisspeptin
affects many physiological processes throughout the body.
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The Kiss1 gene encodes the pre-prohormone Kisspeptin-234 (Kp-234), which is
biologically inactive in mammalian and non-mammalian species (Ronnekleiv and Kelly,
2013). Kisspeptin-234 is cleaved into one of four biologically active forms that can bind
to the Kiss1-receptor. The four biologically active forms of kisspeptin in mammalian
species are Kisspeptin-54 (Kp-54), Kisspeptin-14 (Kp-14), Kisspeptin-13 (Kp-13), and
Kisspeptin-10 (Kp-10). Amino acid sequences of these four proteins are highly conserved
among mammalian species (Kotani et al., 2001; Ohtaki et al., 2001). The carboxyterminus is the most highly conserved region among all mammalian species and confers
the biological activity of kisspeptins (Colledge, 2008; Pasquier et al., 2014). Also, the 2,
4, 6, 7, 8, and 9 amino acids are completely conserved across mammalian species
sequenced to date (Pasquier et al., 2014). The kisspeptin isoforms vary in length among
mammalian species (De Bond and Smith, 2014).
Kisspeptins bind to their cognate receptor with high affinity. The Kiss1R gene
encodes the Kiss1 derived protein receptor (GPR54), which is 398 amino acids in length.
Kisspeptin1 derived protein receptor is a G-protein coupled receptor (GPR) (Pasquier et
al., 2014) and acts through the classical GPR pathway. When the biologically active
kisspeptins bind to GPR54, intracellular metabolic pathways including protein kinase are
activated (Glanowska and Moenter, 2015; Liu et al., 2008). All of the four biologically
active forms of kisspeptins can bind to GPR54.
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Site of action of kisspeptin and its actions on GnRH
Gonadotropin releasing hormone (GnRH) is important for successful reproduction
in numerous mammalian and non-mammalian species. This decapeptide has been shown
to have actions in the hypothalamus through ultra-short feedback, however its actions are
primarily in the AP causing the synthesis and release of the gonadotropins LH and FSH
(Cai and Zhang, 2005; Jackson et al., 2013; Karsch and Evans, 1996). Gonadotropin
releasing hormone neurons are highly abundant in the hypothalamus in many species
including the pig (Silverman et al., 1987; Silverman et al., 1979). In most mammalian
species including the pig, there are two particular regions of interest: the surge center and
the tonic center, which control the release of GnRH.
Though it is plausible that kisspeptin elicits the release of hormones in many
tissues in the body, it is thought that its main actions are within the hypothalamus to
cause the release of GnRH and subsequent gonadotropin release. In the presence of a
GnRH antagonist the stimulatory effects of kisspeptin on gonadotropin release are
attenuated in female mice, rats, sheep, and monkeys (Matsui et al., 2004; Navarro et al.,
2005; Plant et al., 2006; Roseweir et al., 2009; Smith et al., 2011). Peripheral
administration of kisspeptin-54 has been shown to activate GnRH neurons in the
hypothalamus (Caraty et al., 2007). Peripheral administration of kisspeptin to sheep
caused an increase in GnRH concentrations in the cerebrospinal fluid (CSF) in sheep
(Matsui et al., 2004; Messager et al., 2005).
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Data also support the implication that kisspeptin acts on GnRH neurons due to the
anatomical intimacy between GnRH neurons and kisspeptin receptors. The
neurohormone kisspeptin is thought to elicit the release of GnRH via an intimate
connection of kisspeptin neuronal axons associated with dendrites of GnRH neurons
(Hrabovszky et al., 2007). This was discovered through double-immunostaining for
kisspeptin and GnRH neurons (Hrabovszky et al., 2007). Research has also indicated that
GPR54 is expressed by GnRH neurons and is directly stimulated by kisspeptin to cause
GnRH release (Muir et al., 2001; Navarro et al., 2004). More than 70% of GnRH neurons
are co-expressed with kisspeptin receptor mRNA in the rat hypothalamus (Irwig et al.,
2004). In the rat, it has also been demonstrated that kisspeptin immunoreactive nerve
elements directly adjoin to GnRH nerve elements in the hypothalamus (Uenoyama et al.,
2011). It has also been shown that kisspeptin stimulated the release of GnRH from rat
hypothalamic explants (Thompson et al., 2004). These data indicate that kisspeptin may
stimulate the release of GnRH from GnRH neurons in certain areas of the hypothalamus
(Uenoyama et al., 2011).
While it is thought that the predominant actions of kisspeptin are in the
hypothalamus through its actions on GnRH neurons, it has also been thought that
kisspeptin may act directly on the anterior pituitary gland (AP). In AP cell cultures from
adult female baboons, kisspeptin elicited the release of LH in a dose-dependent manner
(Luque et al., 2011). Kisspeptins have been demonstrated to elicit the release of LH and
FSH from the AP in nonmammalian vertebrates (Elizur, 2009; Tobari et al., 2010),
rodents (Revel et al., 2006), ungulates (Decourt et al., 2008; Franceschini et al., 2006; Li
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et al., 2008; Magee et al., 2009; Ohkura et al., 2009; Pompolo et al., 2006), and primates
(Hrabovszky et al., 2007; Seminara et al., 2003). It is thought that kisspeptins act through
direct association with GnRH neurons as well as kisspeptins release into the
hypothalamohypopheseal vascular plexus to associate with the gonadotrophs directly
(Dungan et al., 2006; Ezzat et al., 2010). Additionally, estradiol-17 (E2) increased the
release of LH from AP cells when treated with kisspeptin (Luque et al., 2011). Similarly,
in the rat, another study indicates that when rat anterior pituitary cells were incubated
with kisspeptin-10, LH was increased in a dose dependent manner (Navarro et al., 2005).
On the contrary, Thompson et al. (2004) demonstrated that there was no release of LH
from cultured anterior pituitary cells during treatment of pharmacological doses of
kisspeptin in the rat. Another study in female and male rats indicated that when
kisspeptin-54 was incubated with cultured anterior pituitary cells there was no in vitro
LH or FSH release, even after the pituitary cells were primed with E2 (Matsui et al.,
2004). Though kisspeptins have some effect on the release of the gonadotropins from
cultured anterior pituitary cells, research seems to be equivocal as to whether kisspeptin
acts on the AP directly.
Lents et al. (2008) administered kisspeptin-10 peripherally and centrally to pigs
and reported that it caused an increase in circulating concentrations of LH. Anterior
pituitary cultures from the bovine and porcine species elicited LH release in response to
kisspeptin in a dose dependent manner, however, pharmacological doses were required
(Suzuki et al., 2008). Suzuki et al. (2008) also demonstrated that LH release occurred
within cultured AP cells in response to physiological doses of GnRH. This supporting
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evidence suggests that in addition to GnRH, kisspeptin may also increase the release of
LH through the GnRH pathway (Messager, 2005).
Kisspeptin-54 is a key hormone influencing the regulation of reproductive
function and development (Adachi et al., 2007; Gottsch et al., 2004). Centrally
administered kisspeptins stimulate the release of GnRH in prepubertal and pubertal
female mice and rats (Gottsch et al., 2004; Kinoshita et al., 2005). There is also
supporting evidence that in Kiss1R knockout mice, kisspeptin is not able to stimulate the
release of FSH and LH which is thought to be through the GnRH pathway (Messager et
al., 2005). Additionally, during treatment with acyline, a potent GnRH antagonist, the
kisspeptin-mediated release of LH was completely inhibited (Gottsch et al., 2004).
During ICV treatment with kisspeptin there was an increase in the release of GnRH in the
mouse (Messager et al., 2005). When kisspeptin is incorporated with GnRH neurons in
vitro, there is a potent increase in GnRH neuronal firing (Han et al., 2005; Zhang et al.,
2008). These data support the notion that the stimulatory actions of kisspeptin seem to be
mainly on GnRH neurons.
Over the past decade there have been a multitude of publications pertaining to the
influence of Kiss1 and kisspeptins and the regulation of GnRH secretion (Gottsch et al.,
2004; Messager et al., 2005; Novaira et al., 2009). In addition to the association between
Kiss1, kisspeptin, and GnRH, there have also been studies describing the regulation of
the expression of hypothalamic Kiss1 in correspondence with E2 in mice and rats (Oakley
et al., 2009; Smith et al., 2005a). An increase in E2 causes an increase in the expression of
hypothalamic Kiss1 in the anteroventral periventricular nucleus (AVPV) but decreases
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the expression of hypothalamic Kiss1 in the arcuate nucleus (ARC) in the female mouse
(Smith et al., 2005a; Smith et al., 2006b). The location in which the expression of
hypothalamic Kiss1 is up-regulated is of importance because the positive feedback
effects of E2 are primarily exhibited on the AVPV in rodent species (Petersen and
Barraclough, 1989; Wiegand et al., 1980).
Although correspondence of the expression of hypothalamic Kiss1 and E2 is true
in mice and rats, the concept in sheep is somewhat different. In sheep, the primary region
that receives positive feedback of E2 is the preoptic area (POA) indicating that the basal
and mediobasal hypothalamus (MBH) may be sufficient in maintaining the steroidmediated release of GnRH (Caraty et al., 1998). Regardless of the region of regulation of
the expression of hypothalamic Kiss1 by E2 in the brain, kisspeptin potently excites
GnRH neurons in all instances indicating that specific areas within the hypothalamus may
be influenced by kisspeptin and involved in the release of GnRH and LH.
Mechanisms by which E2 and progesterone (P4) feed back to the hypothalamus
and AP are also of great importance in the control of GnRH and the LH surge. For the
GnRH surge to occur there have to be threshold concentrations of E2 in the absence of P4
(Clarke and Cummins, 1984; Everett and Sawyer, 1950; Harris et al., 1999; Moenter et
al., 1993; Richter et al., 2001). Past research is equivocal as to whether GnRH neurons
express E2- and P4-receptors in mammalian species. Gonadotropin releasing hormone
neurons do express estrogen receptor-beta (ER-) in humans (Hrabovszky et al., 2007).
This supports the notion that E2 can directly affect GnRH neurons thus changing the
animals’ endocrine status. However, it is thought the ER- receives the signals for
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negative estrogen feedback when positive feedback through estrogen receptor-alpha (ER is needed for the GnRH surge to occur in the mouse (Glidewell-Kenney et al., 2007).
In the female mouse there are positive, but not negative, feedback actions of E2 through
ER- in kisspeptin neurons (Dubois et al., 2015). It has not been demonstrated that
GnRH neurons express ER- (Herbison and Theodosis, 1992; Lehman and Karsch,
1993). Therefore, other neurons upstream of GnRH neurons that possess ER- have been
considered as possible mediators of steroidal effects on GnRH release.
Dual immunofluorescence revealed that neurons containing kisspeptin-10
expressed ER- (Franceschini et al., 2006). The majority of cells expressing kisspeptin
neurons co-expressed progesterone receptors (PR) in the ARC in sheep (Smith et al.,
2007). Regulation of the expression of hypothalamic Kiss1 is likely to be a mediator of
negative feedback in multiple species (Adachi et al., 2007; Franceschini et al., 2006;
Goodman et al., 2007; Smith et al., 2005a; Smith et al., 2005b). There is also supporting
evidence that reduced activity of kisspeptin neurons in the hypothalamus of many
mammalian species is responsible for the relay of negative feedback effects of E2 to
GnRH neurons. Castrated male and ovariectomized (OVX) female mice had increased
levels of the expression of hypothalamic Kiss1 versus gonadally intact female mice
(Smith et al., 2005a; Smith et al., 2005b). There was also an increase in the expression of
hypothalamic Kiss1 in OVX sheep and primates versus controls (Pompolo et al., 2006;
Rometo et al., 2007; Shibata et al., 2007). During estrogen administration to OVX female
sheep, the expression of hypothalamic Kiss1 returns to levels not different from control
animals after not being administered estrogen (Pompolo et al., 2006; Rometo et al., 2007;
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Shibata et al., 2007). The expression of ARC Kiss1 was increased, however the
expression of POA Kiss1 was decreased in OVX ewes (Smith et al., 2007). Intact ewes
that exhibited normal steroid feedback had decreased expression of hypothalamic Kiss1
during times of anestrous (Smith et al., 2007). Moreover, the number of kisspeptin
positive cells in the ARC of OVX ewes was reduced by treatment of E2 and P4 (Smith et
al., 2007). Kisspeptin neurons are associated with ER-, PR, and androgen receptors and
therefore have the potential to relay steroidal feedback effects onto GnRH neurons
(Dubois et al., 2015; Roseweir and Millar, 2009). Though exact mechanisms are
unknown, these data suggest that steroids can regulate the expression of hypothalamic
Kiss1, thereafter stimulating GnRH neurons.
Effects of acute kisspeptin administration on LH secretion
Luteinizing hormone, and the preovulatory LH surge are of utmost importance for
mammals to successfully reproduce. In most instances during peripheral, intravenous
(i.v.), and central acute administration, kisspeptin has been shown to stimulate
gonadotropin release. Though kisspeptin has been shown to act primarily in the
hypothalamo-pituitary axis with very low circulating levels in the blood, peripheral
administration of kisspeptin has been demonstrated to consistently stimulate the release
of gonadotropins in a number of mammalian species.
The plasma half-life of Kisspeptin-10 in vivo is very short - only 4 minutes in the
human (Jayasena et al., 2011). Kisspeptin-54 also has a short in vivo plasma half-life of
about 25 minutes in the human (Dhillo et al., 2005). Therefore, i.v. administration of
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kisspeptin-10 would be expected to have a short duration of effects and/or may need to be
administered at pharmacological levels to elicit the release of gonadotropins. Matsui et al.
(2004) demonstrated that a subcutaneous administration of 6.7 nmol of human kisspeptin54 in pre-pubertal female rats elevated plasma LH levels 10-fold from baseline levels 2
hours after injection. Additionally, administration of kisspeptin-54 caused ovulation in a
large percentage of follicles, similar to the effects of human chorionic gonadotropin
(hCG) (Matsui et al., 2004). It has also been demonstrated that male rats (10 weeks of
age) that were administered subcutaneous equimolar doses of kisspeptin-54 and GnRH
responded to the two hormones in almost an identical fashion, indicating that kisspeptin54 and GnRH are equally effective at stimulating the release of LH (Thompson et al.,
2009).
During central and peripheral administration of kisspeptin-10 in GnRH-primed,
castrated rhesus monkeys, researchers observed that 100 g of kisspeptin-10
administered both centrally and peripherally induced the release of LH (Shahab et al.,
2005). During both ICV and i.v. infusions plasma concentrations of LH increased more
than 20-fold by 30 minutes after the start of kisspeptin-10 infusion and continued to be
elevated for approximately 2 hours (Shahab et al., 2005). However a smaller dose of 30
g kisspeptin-10 stimulated LH secretion in a lesser manner (Shahab et al., 2005).
The effects of i.v. administration of kisspeptin-10 were also studied in livestock
species. Human kisspeptin-10 was infused intravenously into pubertal, female goats in
the luteal phase in a dose dependent manner. Circulation concentrations of LH increased
greater than 4-fold 20 to 30 minutes following infusion (Hashizume et al., 2010).
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Similarly in cattle, an intravenous and intramuscular bolus of kisspeptin-10 at 100 and
200 pmol/kg increased plasma LH levels 9.7- and 3-fold, respectively (Whitlock et al.,
2008). Additionally, an intravenous infusion of kisspeptin-10 at doses of 0.77, 1.54, and
3.84 mol to pre-pubertal gilts stimulated an increase in LH to a similar degree following
all doses (Lents et al., 2008). Therefore, kisspeptin-54 and -10 are effective in stimulating
LH secretion whether given centrally, intravenously, intramuscularly, or subcutaneously
to a number of species, including the pig.
Kisspeptin and the estrous cycle
The average estrous cycle of the pig is approximately 21 d in length of which the
follicular phase and luteal phase are approximately 5 d and 16 d in length, respectively.
The follicular phase is the time during which concentrations of E2 are increased and P4
are decreased. Additionally, the GnRH and LH surge and ovulation occur during this
period. During the luteal phase, serum concentrations of P4 are increased and serum
concentrations of E2 are decreased. Corpora lutea (CL) are producing P4 during this phase
and concentrations of E2 are decreased since there is a decrease in the pulsatility and
amplitude of LH. Therefore, the follicular phase of the estrous cycle is of particular
interest because it is a time coincident with increased hypothalamic concentrations of
kisspeptin, the GnRH and LH surge, and the subsequent ovulation.
The amplitude and frequency of LH release are of importance during normal
reproductive cyclicity in mammals. In order for ovulation to occur LH has to reach a
threshold level – this being termed the preovulatory LH surge. Past research indicates that
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kisspeptin plays a pivotal role in the generation of the LH surge. During ICV infusion of
kisspeptin-10 in the pig there was a LH surge (Pineda et al., 2010). Caraty et al. (2007)
demonstrated that constant i.v. infusion of kisspeptin-10 for 8 h beginning 30 h after P4
withdrawal, resulted in an earlier LH surge compared to ewes treated with a placebo
infusion (Caraty et al., 2007). Intravenous infusion of kisspeptin-10 also stimulates an LH
surge in anestrous ewes (Sebert et al., 2010). Ewes treated with Kiss1-receptor antagonist
p-271 did not exhibit an E2 induced LH surge (Smith et al., 2007).
Kisspeptin is thought to exert most of its actions in certain areas of the
hypothalamus through the GnRH pathway. In vitro studies have shown kisspeptin to act
at the level of the AP, but not in vivo studies. Cultures of ovine anterior pituitary cells
responded to kisspeptin treatment exhibiting LH release in a dose dependent manner,
however pharmacological doses of kisspeptin were required to elicit this response
(Suzuki et al., 2008). Hypothalamo-pituitary-disconnected (HPD) ewes did not respond
to kisspeptin-10 treatment as there was no difference in concentrations of LH versus ewes
that did not have a HPD (Smith et al., 2008). There was an increase in the number of
kisspeptin positive cells in the ARC and an increase in the expression of ARC and POA
Kiss1 during the follicular phase in the ewe, a time coincident with ovulation (Estrada et
al., 2006; Smith et al., 2007). Smith et al. (2009), also demonstrated that there was an
increase in the percentage of kisspeptin cells in the ARC during acute administration of
E2 in intact ewes versus OVX ewes administered a chronic dose of E2 the response in
intact ewes was greater (Smith et al., 2009). These data indicate that kisspeptin is
seemingly obligatory for the generation of the GnRH surge and the subsequent LH surge.
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However, it is unclear if kisspeptin acts at the level of the AP, in vivo, under normal
physiological conditions.
Kisspeptin and puberty
The attainment of puberty and hormonal patterns that coincide with the attainment
of puberty are important concepts to understand. There are many definitions indicative of
puberty: the first time a female ovulates, the first time a female exhibits estrus, the first
time the preovulatory LH surge occurs, and the first time a female can carry an
embryo/fetus to term without it having deleterious effects to her body. Though there are
advantages and disadvantages to each of these definitions, the first time a female stands
in a natural estrus is one of the easiest to use from a research standpoint.
In the gilt, age at puberty is positively correlated with age at first boar exposure
(Filha et al., 2009). For best results, gilts are brought to boars where they interact with the
boar through sight, sound, smell, and tactile stimulation. Past studies have shown that
relocation followed by exposure to a mature boar can induce puberty in gilts without the
use of exogenous hormones. Gilts also have to be of proper physiological maturity in
order to attain puberty naturally. Puberty in the gilt, as described by the first preovulatory
LH surge, is attained when there is a decrease in the sensitivity to the negative feedback
effects of E2 which allows the LH surge to occur. During the first GnRH surge and
subsequent LH surge the gilts hypothalamus shifts from being controlled in a negative to
positive steroid feedback fashion. During relocation and boar exposure, this physiological
shift can be achieved causing the subsequent natural attainment of puberty. As the gilt
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attains puberty there is also an increase in FSH, which causes the development of
follicles that synthesize microgram amounts of E2. These physiological factors contribute
to the attainment of puberty in the gilt although the exact mechanisms by which these
hormones are released is not fully understood.
There are an abundance of hormones and growth factors that contribute to the
attainment of puberty. Of those hormones and growth factors, kisspeptin and hormones
associated with kisspeptin are of interest. Neurokinin B (NKB) is a tachykinin and has
been demonstrated to have effects on the secretion of GnRH in the ewe (Goodman et al.,
2014). Neurokinin B is co-expressed with kisspeptin in a large number of hypothalamic
cells in sheep indicating NKB may also play a role in the initiation of puberty (Nestor et
al., 2012). When prepubertal ewes were injected with senktide, a NKB agonist, there was
an immediate pulse of LH versus animals that were administered vehicle (Nestor et al.,
2012). Additionally, there was an increase in kisspeptin positive cells in the
hypothalamus after the attainment of puberty in intact ewes as well as in prepubertal
OVX ewes versus intact prepubertal ewes (Nestor et al., 2012). Peripheral administration
of kisspeptin-10 caused an increase in circulating plasma concentrations of GH in
prepubertal heifers (Nestor et al., 2012). Insulin-like growth factor I has been
demonstrated to have positive effects on the LH surge in a number of species (Adam et
al., 2000; Stewart et al., 1996). Insulin-like growth factor-I can also induce an increase in
hypothalamic Kiss1 mRNA expression during the onset of puberty in the rat, although the
signaling pathway by which this occurs remains elusive (Hiney et al., 2009). Hiney et al.
(2009) demonstrated that when rats were administered alcohol, an IGF-I inhibitor, there
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was a decrease in the expression of hypothalamic Kiss1. Rats that were administered
IGF-I with saline instead of alcohol showed an increase in the expression of
hypothalamic Kiss1 (Hiney et al., 2009). These data indicate that several physiological
factors influence the hypothalamic kisspeptin system which may have implications
during the attainment of puberty.
Many mammalian species exhibit different hormonal patterns during central and
peripheral infusion of when kisspeptin antagonists. Extensive in vitro and in vivo
kisspeptin research has been conducted in a number of mammalian species, including the
pig. During ICV infusion of kisspeptin antagonist (p-234) there was a decrease in LH
pulse amplitude in the ewe – the level of LH was decreased to the extent in which a pulse
no longer occurred (Roseweir et al., 2009). There was also a decrease in plasma
concentrations of LH (Roseweir et al., 2009). Central infusion of p-234 during the
peripubertal period in female rats caused delayed vaginal opening, and decreased uterine
and ovarian weights during the expected time of puberty (Pineda et al., 2010). Chronic
ICV administration of p-234 for 4 d prevented the subsequent LH and FSH surge during
the time of the expected GnRH surge (Pineda et al., 2010). Systemic administration of
labeled p-234 attenuated the acute release of LH and FSH while females were also
administered kisspeptin-10 systemically (Pineda et al., 2010). Additionally, through the
administration of the Kiss1-receptor antagonist p-271 there was a decrease in LH
concentrations in OVX ewes (Smith et al., 2011). Cultures of mouse MBH explants that
were incubated with kisspeptin in a dose dependent manner for 1 h elicited GnRH
release, whereas this did not occur in GPR54 null animals (de Tassigny et al., 2008).
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These data demonstrate that kisspeptin antagonists have a negative effect on reproductive
biology and normal reproductive cyclicity.
Kisspeptin is also important during the attainment of puberty and normal
reproductive cyclicity in the human. One major area of concern is that in which humans
suffer from hypogonadotrophic hypogonadism (HH). Hypogonadotrophic hypogonadism
is characterized by a decrease in the function and release of the gonadotropins from the
AP and a decrease in the function and weight of the gonads. Multiple studies have
indicated that a decrease in the expression of hypothalamic of Kiss1 causes HH in the
human and the mouse (d'Anglemont de Tassigny et al., 2007; Topaloglu et al., 2012).
Additionally, there is also evidence that mutations in the Kiss1R and GPR54 decrease the
effects that kisspeptins have on the hypothalamo-pituitary-gonadal axis (Semple et al.,
2005). After central and peripheral administration of kisspeptins in rats there was a dose
dependent increase in circulating plasma levels of LH (Thompson et al., 2004). These
data indicate that kisspeptin and GPR54 have added a new critical dimension to the
physiological actions within the HPG axis.
Kisspeptin restores normal reproductive cyclicity in humans and this moves one
to believe that kisspeptin could also be used in a similar fashion in livestock species.
Although GnRH is currently used and effectively works to cause ovulation, there may be
other associations kisspeptin has on the hypothalamo-pituitary-gonadal axis. Not only
may kisspeptin be used to treat animals with reproductive disorders but it could also be
used as a diagnostic tool. Previous research has lead scientists to believe that if there are
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decreased peripheral concentrations of kisspeptin the animal may be inferior to its
cohorts.
Other physiological signaling associated with kisspeptin
A majority of the work involving kisspeptin has focused on its interaction with
and control of the release and regulation of GnRH. Although this has been proven to be
true, kisspeptin is also thought to be integrated with metabolism and other hormones
critical in the regulation of reproduction, pregnancy, and lactation. Metabolic signals and
energy balance are important factors that influence the success of the attainment of
puberty and reproductive cyclicity and any disruptions in such aspects may be linked to
reproductive failure. Because the interactions between reproduction and metabolism are
multifaceted, it is highly likely that kisspeptin plays a role in metabolic processes in the
mammalian body.
To date, there has been extensive research that links leptin, growth hormone, and
IGF-I to the expression of hypothalamic Kiss1 and plasma concentrations of kisspeptin,
however it must be stressed that a majority of these studies have used in vitro
experiments and the in vivo experiments that have been performed have used
pharmacological doses to elicit a response. Although precautions should be taken as to
whether these responses occur physiologically it is plausible that some of them may and
it is worthwhile mentioning the association of kisspeptin and metabolic factors. In
gonadectomized ob/ob mice there was a suppression of the expression of hypothalamic
Kiss1 when leptin was absent (Smith et al., 2006a). Also, during the re-administration of
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leptin there was a restoration of the expression of hypothalamic Kiss1 (Smith et al.,
2006a). Central infusion of leptin in a dose dependent manner to male rats with
uncontrolled diabetes and hypogonadotrophic hypogonadism has been shown to
normalize the expression of hypothalamic Kiss1 (Castellano et al., 2006). It has also been
documented that leptin administration increased the expression of ARC and POA Kiss1
mRNA (Backholer et al., 2010). It was also demonstrated that the leptin receptor gene
was expressed in Kiss1 neurons in the arcuate nucleus and preoptic area (Backholer et al.,
2010). These data support the notion that kisspeptin may be a modulator, through leptin
status, of GnRH neurons and release which promotes proper function of the reproductive
axis.
There is a correlation between plasma levels of GH and LH, therefore it is
plausible that there is a like between kisspeptin and GH. Cultured bovine anterior
pituitary cells that were directly treated with kisspeptin-10 in a dose-dependent manner
responded accordingly with a dose dependent increase in the secretion of GH (Kadokawa
et al., 2008). Similarly, cultured rat anterior pituitary cells incubated with kisspeptin-10
responded similarly (Gutierrez-Pascual et al., 2007). Cultured anterior pituitary cells from
nonhuman primates also exhibited the release of GH in response to treatment of
kisspeptin-10 (Luque et al., 2011). This evidence is suggestive of a link between
kisspeptin and GH, however, research is equivocal. During the administration of
kisspeptin to prepubertal cattle and prepubertal female pigs, there was no increase in
circulating concentrations of GH (Ezzat Ahmed et al., 2009; Lents et al., 2008). Although
research is equivocal as to whether physiological levels of kisspeptin increase the release
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of GH, further exploration of the concept is necessary to conclude the exact mechanisms
by which kisspeptin and GH interact.
Another hormone that may influence kisspeptin signaling is IGF-I. Although
insulin infusion does not appear to control the regulation of the expression of
hypothalamic Kiss1 in diabetic rats, there are implications that IGF-I and other growth
factors may regulate the expression of hypothalamic Kiss1 (Luque et al., 2007). In
addition to in vivo regulation of the expression of hypothalamic Kiss1, hypothalamic cell
cultures (N6) that were treated with insulin did not exhibit an increase in the expression
of hypothalamic Kiss1. Hiney et al. (2009) reported that IGF-I stimulated Kiss1 gene
expression in the hypothalamus 6 hours post administration. During that experiment it is
also worthy of noting that plasma concentrations of E2 did not change during or after the
infusion of IGF-I, therefore E2 did not cause the change in the expression of hypothalamic
Kiss1 (Hiney et al., 2009). There was a marked increase in the release of LH, presumable
through the GnRH pathway, in ovariectomized female rats that were injected with IGF-I
or an IGF-I inhibitor during intramuscular administration of kisspeptin. (Neal-Perry et al.,
2014). Under these conditions, IGF-I also increased the kisspeptin-induced LH release
without an increased number of GnRH immunoreactive cells (Neal-Perry et al., 2014).
Collectively, these data indicate that there may also be a link between the IGF-I and
kisspeptin systems in the control and regulation of the release of GnRH and LH.
A link may exist between pregnancy and lactation specific hormones and
kisspeptin. During intravenous kisspeptin administration to non-pregnant female rats
plasma concentrations of oxytocin were increased (Kotani et al., 2001). During
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pregnancy in the human there is a dramatic increase in plasma concentrations of
kisspeptin. From baseline, there is approximately an 850-fold increase in plasma
concentrations of kisspeptin in the first trimester and approximately a 7,000-fold increase
in plasma concentrations of kisspeptin in the third trimester (Dhillo et al., 2007). The
main source of the increased plasma concentrations of kisspeptin during pregnancy may
be stemming from the placenta because the expression of Kiss1 and kisspeptin have been
found in the syncytiotrophoblastic cells of the placenta (Horikoshi et al., 2003). The exact
reason for the increase in kisspeptin during pregnancy is unknown and it would be
worthwhile further investigating this concept in other species.
Summary and Conclusion
Kisspeptin plays an important role in the regulation of GnRH and LH during the
estrous cycle and attainment of puberty. It has been demonstrated that central and
peripheral infusion of kisspeptin stimulate the release of GnRH and/or LH. In vitro,
kisspeptin has also been shown to elicit the release of LH from anterior pituitary cells.
During the attainment of puberty, prepubertally, and after ovariectomy, peripheral
administration of kisspeptin-10 increased circulating plasma levels of LH in the bovine
species. There are also implications that kisspeptin is associated with metabolic factors as
well as pregnancy and lactation specific hormones. Although the mechanisms of
kisspeptins actions are not fully understood and future studies may provide more insight
into the matter, it is widely accepted that kisspeptin and the expression of hypothalamic
Kiss1 is highly associated with hypothalamic signaling in reproductive physiology.
Kisspeptin has been demonstrated to play a role in reproductive cyclicity throughout the
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estrous cycle and during the attainment of puberty in the gilt, however, changes in the
hypothalamic kisspeptin system and other related reproductive hormones have not been
determined throughout the estrous cycle and during the peripubertal period in the gilt.
Therefore, the objectives of the following studies was to ascertain the relationship
between peripheral concentrations of E2 and P4, AP concentrations of kisspeptin, LH,
and IGF-I, MBH concentrations of kisspeptin, AP expression of GnRHR and LH-, and
MBH expression of Kiss1, Kiss1R, ER-, and ER-.
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Chapter 2
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM
THROUGHOUT THE ESTROUS CYCLE IN GILTS

Introduction
Kisspeptin administration has been found to increase serum concentrations of LH
in a number of species. Kisspeptin has also been found to cause the release LH from AP
cell cultures and/or cause release of AP LH in cattle (Whitlock et al., 2008), sheep
(Sebert et al., 2010), and pigs (Lents et al., 2008); presumably through the GnRH
pathway. Intravenous administration of kisspeptin-10 caused a 4-fold increase in plasma
concentrations of LH within 30 minutes in the goat (Hashizume et al., 2010). Similarly in
cattle, during intravenous and intramuscular infusion of kisspeptin-10, there was a 9.7and 3-fold increase in plasma concentrations of LH, respectively (Whitlock et al., 2008).
Pineda et al. (2010) found that there was a LH surge during ICV infusion of kisspeptin-10
in pigs. Intravenous infusion of increasing doses of kisspeptin-10 to pre-pubertal gilts
also stimulated an increase in LH to a similar degree (Lents et al., 2008). Therefore, these
studies indicate that the administration of kisspeptin via ICV and intravenous infusion
caused an increase in peripheral concentrations of LH in a number of mammalian species.
Anterior pituitary cell cultures from adult female baboons released LH in
response to kisspeptin in a dose dependent manner (Luque et al., 2011). In the rat, LH
was released in a similar fashion to that of the baboon upon kisspeptin treatment (Navarro
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et al., 2005). The release of LH from anterior pituitary cultures has also been
demonstrated in the horse (Decourt et al., 2008), fish (Elizur, 2009), and sheep
(Franceschini et al., 2006).
Recently, research has been performed to ascertain the relationship between the
expression of hypothalamic Kiss1 and plasma concentration of estradiol-17 (E2)
(Oakley et al., 2009; Smith et al., 2005a). An increase in circulating concentrations E2
caused an increase in the expression of anteroventral periventricular nucleus (AVPV)
Kiss1 but decreased the expression of arcuate nucleus (ARC) Kiss1 in the female mouse
(Smith et al., 2005a; Smith et al., 2006b). In the rat, the expression of AVPV Kiss1 peaks
at a time coincident with the pre-ovulatory LH surge and Kiss1 neurons express c-Fos
induction at a coincident time (Adachi et al., 2007; Smith et al., 2006b). Clarkson et al.
(2008) reported that mice bearing deletions in the Kiss1R appear to lack the capacity to
exhibit an LH surge versus mice that were ovariectomized and then treated with estrogen
and progesterone. Hence, it is plausible that an increase in the expression of
hypothalamic Kiss1 may contribute to the pre-ovulatory GnRH/LH surge in the pig.
It is widely accepted that there is a pre-ovulatory LH surge around d 19 of the
estrous cycle in the pig (Henricks et al., 1972). Leading to the time of the pre-ovulatory
LH surge, there is a decrease in plasma concentrations of P4 followed by an increase in
plasma concentrations of E2 (Henricks et al., 1972). These events then lead to a standing
estrus which occurs at a time temporally related to ovulation. Smith et al. (2009)
demonstrated that the number of identifiable Kiss1 mRNA expressing cells and the Kiss1
mRNA expression per cell in the pre-optic area (POA) were greater during the late
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follicular phase versus the luteal phase in the sheep. This was also true for the number of
identifiable Kiss1 mRNA expressing cells in the caudal and middle parts of the ARC
(Smith et al., 2009). Smith et al. (2009) also demonstrated that there was a 2-fold increase
in kisspeptin-immunoreactive cells in the ARC during the late-follicular phase of the
estrous cycle versus the luteal phase of the estrous cycle. These data indicate that there is
a link between kisspeptin and Kiss1 mRNA expression during the events that occur
during estrus in mammals.
Kisspeptin has been demonstrated to play a critical role in the regulation of
reproduction through multiple endocrine pathways, however, the changes in kisspeptin
and related reproductive hormones throughout the estrous cycle in the gilt are yet to be
determined. Therefore, the objective of this research was to determine serum
concentrations of E2 and P4, anterior pituitary concentrations of LH, kisspeptin, and IGFI, and hypothalamic expression of Kiss1, Kiss1R, ER-, and ER- and concentrations of
kisspeptin on various days of the porcine estrous cycle.
Materials and Methods
Animals
Forty crossbred (Duroc x Large White x Landrace) gilts of similar age (191 ±
11.6 d) and weight (120.7 ± 32.8 kg) were used in this experiment. Gilts were penned
(1.83 m x 2.44 m) into groups of four and received ad libitum access to a corn-soy based
diet that contained 3.4 Mcal ME/kg, 18% protein, and 0.9% lysine and water. Each gilt
was administered an intramuscular injection of PG600 (400 IU equine chorionic
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gonadotropin and 200 IU human chorionic gonadotropin) two days after they were
penned into groups of four. Twelve days after the administration of PG600 gilts were
orally administered 15 mg of altrenogest (Matrix; Merck Animal Health, Kenilworth, NJ)
each day and continuing for 15 d to synchronize estrus. Gilts were exposed to a mature
boar twice daily beginning the fourth day after the cessation of the altrenogest treatment
and continuing for 4 d to detect estrus. The first day gilts stood immobile in the presence
of the boar was designated as d 1 of the estrous cycle.
Ten gilts were slaughtered at the South Dakota State University Meat Lab on days
1, 9, 14, and 21 of the estrous cycle at which time blood samples, anterior pituitaries
(AP), mediobasal hypothalami (MBH), and reproductive tracts were collected. Blood
samples (10 mL) were collected from all gilts on d 1 of the estrous cycle and remaining
gilts that had not yet been slaughtered on days 4, 7, 9, 14, 16, and 19 of the estrous cycle
via jugular venipuncture. Blood samples were allowed to clot overnight at 4ºC then
serum was collected by centrifugation (1,500 x g for 30 minutes at 4ºC) and stored at 20ºC. Anterior pituitary glands and MBH were trimmed of connective tissue, bisected
midsaggitally, wrapped in aluminum foil, snap frozen in liquid nitrogen, and stored at 80ºC. All experimental procedures were reviewed and approved by the Institutional
Animal Care and Use Committee at South Dakota State University.
Estradiol-17
Serum concentrations of E2 were determined in duplicate in all blood samples by
RIA. Estradiol-17 (E8875; Sigma Life Science, St. Louis, MO) was the standard and
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radioiodinated E2 (#07138228; MP Biomedicals, Solon, OH) was the tracer. Antisera
(GDN#244 anti-estradiol-17-6-BSA; Fort Collins, CO) was used at a dilution of
1:425,000. Sera (250-L) were extracted with a 4-mL volume of methyl tert-butyl ether.
Recovery of [125I]estradiol-17 added to porcine serum before extraction averaged 96 ±
2%. Inhibition curves of increasing amounts of sample were parallel to standard curves.
Intra-assay and inter-assay coefficients of variation were 9.2% and 18.6%, respectively.
Sensitivity of the assay was 0.2 pg/tube.
Progesterone
Serum concentrations of progesterone were determined in duplicate in all blood
samples by RIA. Progesterone (P0130; Sigma Life Science; St. Louis, MO) was the
standard and radioiodinated progesterone (#07-170126; MP Biomedicals, Solon, OH)
was used as the tracer. Antisera (#111.2C7.3; Enzo Life Sciences, Farmingdale, NY) was
used at a dilution of 1:700,000. Samples were diluted 1:10 prior to assay. Inhibition
curves of increasing amounts of sample were parallel to standard curves. Intra-assay
coefficient of variation was 12.1%. Sensitivity of the assay was 0.33 ng/tube.
Insulin-Like Growth Factor-I
Anterior pituitary gland concentrations of IGF-I were determined in duplicate by
RIA (Echternkamp et al., 1990; Funston et al., 1995). One half of each anterior pituitary
gland was homogenized in a 15-mL polypropylene tube with 2-mL of homogenization
buffer (1% cholic acid, 0.1% SDS, 200 M phenylmethylsulfonylfluoride, 100 M
EDTA, 1 M leupeptin, and 1 M pepstatin) and homogenized on ice with a T25 Ultra-

27

Turrax tissue dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. Anterior
pituitary glands were then diluted to 100 mg of AP tissue/mL with homogenization
buffer. Homogenates were centrifuged at 12,000 x g for 10 min at 4ºC and the
supernatant was removed and stored at -20ºC. Protein content of the AP homogenates
(1:20 dilution) was determined by the Bradford method using reagents provided by BioRad (Hercules, CA). Insulin-like growth factor binding proteins were extracted from all
homogenized anterior pituitary gland samples with a 1:17 ratio of sample to acidified
ethanol (12.5% 2 N HCl:87.5% absolute ethanol; (Daughaday et al., 1980)). Recombinant
human IGF-I (GF-050; Austral Biological, San Ramon, CA) was used as the standard and
radioiodinated antigen. Antisera (UB2-495; National Hormone and Peptide Program,
NIDDK) was used at a dilution of 1:62,500. Recovery of [125I]IGF-I added to porcine
serum before extraction averaged 91 ±3.2%. Inhibition curves of increasing amounts of
sample were parallel to standard curves. Intra-assay coefficient of variation was 14.8%.
Sensitivity of the assay was 10.9 pg/tube.
Luteinizing Hormone
Anterior pituitary gland concentrations of LH were determined in triplicate by
RIA (Clapper et al., 1998). Porcine LH (AFP3881A; National Hormone and Peptide
Program, NIDDK) was used as the radioiodinated antigen and standard. Luteinizing
hormone antiserum (AFP15103194; National Hormone and Peptide Program, NIDDK)
was used at a dilution of 1:200,000. Anterior pituitary homogenates were diluted
1:25,000 in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing
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amounts of sample were parallel to standard curves. Intra-assay coefficient of variation
was 9.9%. Sensitivity of the assay was 0.12 ng/tube.
Kisspeptin-54
Hypothalamic and AP concentrations of kisspeptin-54 were determined in
duplicate by RIA. Human kisspeptin (1443; Tocris Bioscience, Ellsville, MO) was used
as the radioiodinated antigen and standard. Kisspeptin antiserum (GQ2; provided by
Waljit Dhillo, Imperial College, London, England, UK) was used at a dilution of
1:50,000. The GQ2 kisspeptin antibody cross reacted 100% with human kisspeptin-54,
kisspeptin-14, and kisspeptin-10 and less than 0.01% with any other related human RF
amide protein (Dhillo et al., 2005). Hypothalami and AP homogenates were diluted 1:30
in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing amounts of
sample were parallel to standard curves. Inter-assay coefficients for MBH and AP assays
were 9.4% and 11.2%, respectively. Intra-assay coefficients of variation for MBH and AP
assays were 4.6% and 8.0%, respectively. Sensitivity of the assay was 9.68 pg/tube.
Isolation of RNA
Total RNA was isolated from one half of each AP and MBH using TriReagent
(TR118; Molecular Research Company, Cincinnati, OH). Tissue was homogenized in a
15-mL polypropylene tube containing 1-mL of TriReagent with a T25 Ultra-Turrax tissue
dispenser (IKA Wroks, Wilmington, NC) for 30 s at 20,500 rpm. The resulting
homogenates were diluted to 5-mL with TriReagent. One milliliter of the homogenate
was removed from the 15-mL polypropylene tube and pipetted into a 1.5-mL
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polypropylene tube. One hundred microliters of 1-bromo-3-chloropropane (BCP;
#BP151, Molecular Research Center, Cincinnati, OH) was added to the tubes containing
1-mL of homogenate, mixed, and incubated at room temperature for 5 min. Samples were
centrifuged (12,000 x g for 15 min at 4ºC) and the resulting aqueous layer was removed.
Isopropanol (500 L) was added to the aqueous layer to precipitate the RNA. The
resulting RNA pellet was washed twice with 75% ethanol, centrifuged, dried, and
suspended in nuclease-free water. Concentration of RNA was determined via
spectrophotometer (Nanodrop, Thermo Scientific, Washington, DE). Purity of RNA was
determined by measuring the A260/A280 ratio. The ratio of all samples ranged from 1.8 to
2.0.
cDNA Synthesis
Any contaminating DNA was removed from 10 g of AP RNA and 5 g of MBH
RNA for each sample using the Turbo DNA-Free™ Kit (#AM1907; Ambion, Austin,
TX) following the manufacturer’s protocol. Two micrograms of the resulting RNA was
reverse transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit
containing random hexamer primers (#4374966; Applied Biosystems, Foster City, CA)
following the manufacturer’s protocol.
Porcine Primers
Previously published mRNA sequences for the gene of interest and porcine actin were used to design specific forward and reverse primers. Primers were designed
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using software provided by Integrated DNA Technologies (IDT, Coralville, IA; Table
2.1).
Real-Time PCR
Real-time semi-quantitative PCR was used to measure the quantity of MBH ER, ER-, Kiss1, and Kiss1R, and AP LH- mRNA relative to the amount of porcine actin mRNA in each sample. Measurements of the relative quantity of the cDNA of
interest was carried out using RT2 Real-Time™ SYBR Green/ROX PCR Master Mix
(SuperArray Bioscience Corp., Foster City, CA). Twenty-five microliter reactions were
measured using the Stratagene MX3005P quantitative real-time PCR instrument (Agilent
Technologies, Foster City, CA). Thermal cycling conditions recommended by the
manufacturer (40 cycles of 30 sec at 95ºC, 1 min at 55ºC, and 1 min at 72ºC) were used
for all genes except Kiss1, in which the following thermal cycling conditions were used;
45 cycles of 30 sec at 95ºC, 1 min and 3 sec at 55ºC, and 1 min at 72ºC. Concentrations
of forward and reverse primers used for the genes of interest were 300 nM, except
Kiss1R, in which concentrations of forward and reverse primers were used at a
concentration of 800 nM. A linear response was obtained when these concentrations of
primer pairs were used with increasing amounts of cDNA. Dissociation curve analysis
was performed after each real-time PCR run to confirm that a single amplicon of
appropriate melting temperature was present. Additionally, all amplicons were
electrophoresed through a 2% agarose gel and stained with ethidium bromide to visualize
that only amplicons of the appropriate size were present in each sample.
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Table 2.1
Forward and reverse primers for Real-Time PCR for porcine mRNA
Gene and
Accession Number

Primer

Amplicon Size

pKiss1
(NM_001134964.1)a

Forward
Reverse

89 bp
5’ – GGCAGCTGATGTTCTTTCTTTG – 3’
5’ – CGGGCCTGTAGATCTAGGATT – 3’

pKiss1R
(NM_001044624.2)b

Forward
Reverse

110 bp
5’ – CAGGGAACTCACTTGTCATCTT – 3’
5’ – GCACAGCAGAAACGTCAAATC – 3’

pER-
c

Forward
Reverse

124 bp
5’ – GGACAGGGATGAAGGGAAATG – 3’
5’ – CATGGCCTTGACACAGAGATAC – 3’

pER-
(NM_214220)d

Forward
Reverse

91 bp
5’ – GAATGTTGAAGCACAAGCGCCAGA – 3’
5’ – ACCGGGCTGTTCTTCTTAGTGTGT – 3’

pLH-
(NM_214080.1)e

Forward
Reverse
p-actin
(U07786.1)f
Forward
Reverse
a

151 bp
5’ – ATGCTCCAGAGACTGCTGTTGT – 3’
5’ – TGCTGGTGGTAAAGGTGATGCAGA – 3'

129 bp
5’ – TCGCCGACAGGATGCAGAAGGA – 3’
5’ – AGGTGGACAGCGAGGCCAGGAT – 3’

porcine Kiss1; b porcine Kiss type 1 receptor; c porcine estrogen receptor-beta; d porcine
estrogen receptor-alpha; e porcine luteinizing hormone subunit beta; f porcine beta-actin

32

Statistical Analysis
To determine the effect of day of the estrous cycle on serum concentrations of
estradiol-17and progesterone, hypothalamic concentrations of kisspeptin-54, and
anterior pituitary concentrations of kisspeptin-54, IGF-I and LH, statistical analyses were
performed using the Mixed Procedure of SAS 9.3 (SAS 9.3, SAS). The model for
determining differences in serum concentrations of estradiol-17 and progesterone was
Yijkl =  + Pigi + Treatmentj + Pigi(Treatment)j + Dayk + Treatmentj x Dayk
+Pigi(Treatment)j x Dayk + eijkl with repeated measures. The model for determining
differences in hypothalamic concentrations of kisspeptin-54, and anterior pituitary
concentrations of kisspeptin-54, IGF-I, and LH was Yijkl =  + Pigi + Treatmentj +
Pigi(Treatment)j + Dayk + Treatmentj x Dayk +Pigi(Treatment)j x Dayk + eijkl. Pig within
treatment by day was the subplot error term used to test pig, day, and treatment by day
effects.
Fold differences in expression of MBH Kiss1, Kiss1R, ER-, and ER- and AP
LH- among treatments was determined using the Relative Expression Software Tool
(REST; Corbett Research & M. Pfaffl, Technical University Munich). The expression of
a target gene is standardized by a non-regulated gene. Relative expression is based on the
expression ratio of a target gene versus a reference gene. The expression ratio results of
the investigated transcripts were tested for significance by Pair Wise Fixed Reallocation
Randomized Test (Pfaffl et al., 2002).
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Results
Mean serum concentrations of E2 were greatest (P<0.05) on d 19 of the estrous
cycle and were not different (P>0.05) on days 4, 7, 9, and 14 of the estrous cycle (Figure
2.1). On d 1 of the estrous cycle, mean serum concentrations of estradiol-17 were
greater (P<0.05) than on days 4 and 21 of the estrous cycle (Figure 2.1). Mean serum
concentrations of estradiol-17 were greater (P<0.05) on d 16 compared to d 21 of the
estrous cycle (Figure 2.1).
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Day of the Estrous Cycle
Figure 2.1. Mean serum concentrations of estradiol-17in gilts throughout various days
of the estrous cycle. Means are expressed as least square means ± SEM. abcdMeans with
different letters differ (P<0.05) by day.
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Mean serum concentrations of progesterone followed the typical pattern observed
throughout the estrous cycle in gilts (Figure 2.2). Mean serum concentrations of P4
increased from d 1 through 14 and were greatest (P<0.05) at d 14 of the estrous cycle
(Figure 2.2). From d 14 to d 21 of the estrous cycle mean serum concentrations of P4
decreased (P<0.05) (Figure 2.2).
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Figure 2.2. Mean serum concentrations of progesterone in gilts throughout various days
of the estrous cycle. Means are expressed as least-square means ± SEM. abcdefMeans with
different letters differ (P<0.05) by day.
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Mean AP concentrations of IGF-I were greater (P<0.05) on d 21 compared to d 1
of the estrous cycle (Figure 2.3). No other differences among days of the estrous cycle
were detected (P>0.05) (Figure 2.3).
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Figure 2.3. Mean AP concentrations of IGF-I in gilts (n=10/d) on d 1, 9, 14, and 21 of
the estrous cycle. Data are expressed as least-square means ± SEM. abMeans with
different letters differ (P<0.05) by day.
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Mean AP concentrations of LH were greatest (P<0.05) on day 14 of the estrous
cycle (Figure 2.4). Mean AP concentrations of LH were not different (P>0.05) on days 1
and 9, and 1 and 21 of the estrous cycle (Figure 2.4), however mean AP concentrations of
LH were greater (P<0.05) on day 9 versus 21 of the estrous cycle (Figure 2.4).
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Figure 2.4. Mean AP concentrations of LH in gilts (n=10/d) on d 1, 9, 14, and 21 of the
estrous cycle. Data are expressed as least-square means ± SEM. abcMeans with different
letters differ (P<0.05) by day.
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No differences were detected (P>0.05) in mean AP concentrations of kisspeptin
throughout the estrous cycle (Figure 2.5).
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Figure 2.5. Mean AP concentrations of kisspeptin in gilts (n=10/d) on d 1, 9, 14, and 21
of the estrous cycle. Data are expressed as least-square means ± SEM.
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No differences were detected (P>0.05) in mean MBH concentrations of kisspeptin
throughout the estrous cycle (Figure 2.6).
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Figure 2.6. Mean MBH concentrations of kisspeptin in gilts (n=10/d) on d 1, 9, 14, and
21 of the estrous cycle. Data are expressed as least-square means ± SEM.
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Mean relative expression of MBH ER- did not differ (P>0.05) in gilts
throughout the estrous cycle (Figure 2.7).
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Figure 2.7. Mean relative expression of MBH ER- in gilts (n=10/d) on days 1, 9, 14,
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of
ER-by semi-quantitative real-time reverse transcriptase PCR with normalization for the
corresponding level of -actin. Data are expressed as a fold change in expression relative
to the values in pigs on d 1 of the estrous cycle.
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Mean relative expression of MBH ER-was up-regulated (P<0.05) on days 9 and
14 compared to day 21 of the estrous cycle (Figure 2.8).
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Figure 2.8. Mean relative expression of MBH ER- in gilts (n=10/d) on days 1, 9, 14,
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of
ER-by semi-quantitative real-time reverse transcriptase PCR with normalization for the
corresponding level of -actin. Data are expressed as a fold change in expression relative
to the values in pigs on d 1 of the estrous cycle. abcMeans with different letters differ
(P<0.05) as determined by the relative expression software tool.
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Mean relative expression of MBH Kiss1 was greatest (P<0.05) on d 21 of the
estrous cycle (Figure 2.9). Mean relative expression of MBH Kiss1 was down-regulated
(P<0.05) on days 1 versus 14 and 21 and 9 versus 21 of the estrous cycle (Figure 2.9).
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Figure 2.9. Mean relative expression of MBH Kiss1 in gilts (n=10/d) on days 1, 9, 14,
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of
Kiss1by semi-quantitative real-time reverse transcriptase PCR with normalization for the
corresponding level of -actin. Data are expressed as a fold change in expression relative
to the values in pigs on d 1 of the estrous cycle. abcMeans with different letters differ
(P<0.05) as determined by the relative expression software tool.
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Mean relative expression of MBH Kiss1R did not differ (P>0.05) in gilts
throughout the estrous cycle (Figure 2.10).
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Figure 2.10. Mean relative expression of MBH Kiss1R in gilts (n=10/d) on days 1, 9, 14,
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of
Kiss1Rby semi-quantitative real-time reverse transcriptase PCR with normalization for
the corresponding level of -actin. Data are expressed as a fold change in expression
relative to the values on d 1.
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Discussion
Kisspeptin, a protein produced by most mammalian species, has been found in
many tissues in the body (Li et al., 2008). Kisspeptins are small, neurohormones encoded
by the Kiss1 gene (Kotani et al., 2001). After ICV and intra-ARC infusion of kisspeptin
antibodies there was a profound decrease in serum concentrations of LH in the rat (Li et
al., 2009). Kisspeptin has been shown to elicit the release of LH via ICV, intramuscular,
and intravenous infusion in a number of mammalian species (Lents et al., 2008; Sebert et
al., 2010; Whitlock et al., 2008). Kisspeptin-54 has also been demonstrated to stimulate
the hypothalamo-pituitary gonadal axis in humans (Chan et al., 2012; Dhillo et al., 2005).
Although these studies demonstrated that exogenous kisspeptin can cause the release of
LH, it is also thought that endogenous kisspeptin released by the hypothalamus of
mammals can cause the release of LH.
In the present study, estradiol-17 and progesterone followed patterns that were
indicative of a normal porcine estrous cycle. Henricks et al. (1972) demonstrated that
during the luteal phase (from d 4 to 16 of the estrous cycle) plasma concentrations of
estrogen were low (< 20 pg/mL/animal). Following that, plasma concentrations of
estrogen started to increase and reached their peak (> 50 pg/mL/animal) between 1 and 2
days before estrus (Henricks et al., 1972). Mean plasma concentrations of progesterone
increased dramatically from d 2 to 6 of the estrous cycle and continued until they peaked
by d 12 of the estrous cycle (Henricks et al., 1972). In the present study, serum
concentrations of estrogen started to increase only after plasma concentrations of
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progesterone started to decrease, which was temporally related with the next expected LH
surge.
Insulin-like growth factor-I has been shown to positively associate with estrogen,
in that E2 caused an increase in peripheral and AP concentrations of IGF-I in the pig
(Hilleson-Gayne and Clapper, 2005; Rempel and Clapper, 2002). Estrogens are
synthesized from androgens via aromatase enzymes (Simpson et al., 1994). Anastrozole
is a non-steroidal aromatase-inhibiting compound that has been shown to dramatically
reduce the synthesis of estrogens and reduce plasma concentrations of estrogen by 86%
in women (Geisler et al., 2001; Mauras et al., 2000). Hilleson-Gayne and Clapper (2005)
demonstrated that serum concentrations of IGF-I were greater in boars that were
untreated versus boars that were treated with anastrozole. Estrogen has also been
demonstrated to affect concentrations of AP IGF-I in the pig as well. Rempel and Clapper
(2002) reported that estrogen implanted barrows had greater AP concentrations of IGF-I
versus untreated barrows and boars. These data support the notion that E2 could also
affect the AP concentrations of IGF-I during various days of the estrous cycle. Gilts
slaughtered on the last day of the estrous cycle and at a time directly following greater
serum concentrations of E2 (day 19) had greater AP concentrations of IGF-I versus gilts
that had lesser serum concentrations of E2 directly following a standing estrus on d 1 of
the experiment. Insulin-like growth factor-I has been demonstrated to stimulate the
release of LH from cultured AP cells in rats and pigs (Soldani et al., 1994; Whitley et al.,
1995). Adam et al. (1998) also demonstrated that peripheral administration of IGF-I can
acutely stimulate an increased in plasma concentrations of LH in sheep. Therefore, it is
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plausible that IGF-I may affect the AP LH system and work in concert with kisspeptin to
cause a greater release of LH.
Mean AP concentrations of LH were greatest on d 14 of the estrous cycle and
least on d 1 and 21; a time coincident with a standing estrus and a time temporally related
with the next expected estrus, respectively. These data coincide with the patterns of E2
and P4. Henricks et al. (1972) demonstrated that serum concentrations of LH decreased
after a standing estrus until just before the subsequent estrus when LH increased to its
peak. During the peak in LH, serum concentrations of estrogen were increased and serum
concentrations of progesterone remained decreased (Henricks et al., 1972). Additionally,
Baird and Scaramuzzi (1976) found that basal peripheral concentrations of LH decreased
to a level similar to peripheral concentrations of LH during the luteal phase of the estrous
cycle following subcutaneous P4 implantation in ewes. In the present study, it is plausible
that increased P4, in the face of decreased E2, was providing negative feedback to the
MBH and AP during the luteal phase of the estrous cycle causing a buildup of AP LH
prior to the pre-ovulatory LH surge.
Past research has shown that there is a correlation between circulating
concentrations of sex steroids and hypothalamic concentrations of kisspeptins and
expression of Kiss1 (Kauffman et al., 2007; Smith et al., 2005a; Smith et al., 2005b). In
the present study, there was no difference in MBH and AP concentrations of kisspeptin54 throughout various days of the estrous cycle, however there was an increase in relative
MBH Kiss1 gene expression versus the first day of the estrous cycle compared to the last
day of the estrous cycle. Increased relative MBH Kiss1 gene expression occurred at a
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time coincident with greater serum concentrations of E2 and greater AP concentrations of
LH. Cui et al. (2015) performed an experiment measuring Kiss1 and GnRH gene
expression and protein concentration in multiple areas of the hypothalamus in
ovariectomized (OVX) and rats treated with E2. During the onset of puberty, kisspeptinimmunoreactive cells increased in the ARC, periventricular nucleus, and preoptic areas
(Cui et al., 2015). Levels of both hypothalamic Kiss1 and GnRH gene expression were
greater in OVX + E2 and/or intact + E2 compared to OVX and intact animals that were
not treated with E2 (Cui et al., 2015). Furthermore, hypothalamic expression of Kiss1
mRNA during estrus was decreased versus other stages of the estrous cycle in the rat
(Salehi et al., 2013). These data support the notion that an increase in hypothalamic Kiss1
mRNA and hypothalamic kisspeptin concentration play a role in modulating the activity
of estrogen during the time an animal expresses estrus. Though the timing of sample
collection impacts the outcome greatly, the present study parallels with past research.
During expression of estrus, when serum concentrations of E2 were greater, there was a
decrease in hypothalamic expression of Kiss1 compared to the last day of the estrous
cycle when serum concentrations of E2 were lesser.
Kisspeptins bind to their cognate receptor, GPR54, with high affinity (Messager
et al., 2005). There is evidence that GnRH neurons possess kisspeptin receptors and after
kisspeptin binds to GPR54 there is an increase in hypothalamic concentrations of GnRH
(Messager et al., 2005). The Kiss1R gene has been demonstrated to be highly abundant in
multiple tissues in the body, including the hypothalamus and anterior pituitary gland (Li
et al., 2008). In the present study, hypothalamic Kiss1R gene expression was measured
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on various days of the estrous cycle but no differences among days were found. KisneyJones et al. (Kinsey-Jones et al., 2009) reported that there was a down-regulation of
hypothalamic expression of Kiss1R during a stress-induced suppression of LH in the
female rat. Although there were no differences among days of the estrous cycle it is
plausible that variations in the expression of the Kiss1R gene and the number of
kisspeptin receptors may influence the GnRH pathway and endocrine status of the animal
at a time coincident with a standing estrus.
No differences were detected in mean relative expression of MBH ER-, however
mean relative expression of MBH ER- was decreased on d 21 of the estrous cycle
compared to d 9 and 14 of the estrous cycle and tended to be lesser on d 21 compared to d
1 of the estrous cycle. In the rat, selective blockade of ER- in gonadally intact, cyclic
females decreased the release of LH in response to kisspeptin, inhibited the preovulatory
LH surge, and blocked ovulation (Roa et al., 2008). Roa et al. (2008) also demonstrated
that after selective activation of ER- there was an increase in LH secretion in response
to kisspeptin. This was not the case when ER- was activated (Roa et al., 2008).
Additionally, when rats were treated with an ER- antagonist the preovulatory LH surge
still occurred, however there was a decrease in acute LH responses to kisspeptin (Roa et
al., 2008). Although there are alterations in the MBH expression of ER- and ER-in the
present study, GnRH neurons may not be direct targets for the actions of E2 (Herbison
and Theodosis, 1992; Shivers et al., 1983). Kisspeptin is a potent secretagogue of GnRH
(Dhillo et al., 2005; Gottsch et al., 2004). Additionally, kisspeptin possess estrogen
receptors (Franceschini et al., 2006; Smith et al., 2005a; Smith et al., 2006b), and AVPV
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expression of Kiss1 is up-regulated at a time coincident with the LH surge (Adachi et al.,
2007; Smith et al., 2006b). Therefore, the hypothalamic kisspeptin system and ER- and
– are closely integrated and alterations in hypothalamic expression of ER- and – may
cause increased release of kisspeptin, the subsequent GnRH/LH surge, and the attainment
of puberty in mammalian species.
In conclusion, kisspeptin has been demonstrated to cause the release of LH in vivo
and in vitro in a number of mammalian species, including the gilt (Lents et al., 2008;
Sebert et al., 2010; Whitlock et al., 2008). Recent research has also described the
relationship between increased peripheral concentrations of E2 and increased
hypothalamic concentrations of Kiss1 (Oakley et al., 2009; Smith et al., 2005a; Smith et
al., 2006b). In the present study, there were variations in hypothalamic Kiss1 gene
expression at key time points in the estrous cycle; particularly just before gilts expressed
estrus. Kisspeptin may be an important hormone driving normal reproductive cyclicity,
however the timing at which samples are collected is critical and needs to be further
investigated.
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Chapter 3
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM DURING
THE ATTAINMENT OF PUBERTY IN GILTS

Introduction
Activation of gonadotropin releasing hormone (GnRH) neurons and the release of
GnRH is critical for the attainment of puberty, however, research is equivocal as to
whether GnRH neurons lack estrogen receptors. Therefore other endocrine pathways that
are plausible to cause the preovulatory luteinizing hormone (LH) surge are of interest.
Several researchers have hypothesized that kisspeptin works at the level of the
hypothalamus to activate GnRH neurons and start the onset of puberty. Through the
administration of exogenous kisspeptin it has been shown that kisspeptin increased
hypothalamic concentrations of GnRH at puberty in a number of species including
primates (Skorupskaite et al., 2014), rodents (Messager et al., 2005), and sheep (Li et al.,
2012). Central administration of kisspeptin increased plasma concentrations of LH in
prepubertal female rats versus controls (Navarro et al., 2004). Repetitive administration
of kisspeptin to prepubertal female lambs increased plasma concentrations of sex steroids
and caused a LH surge (Redmond et al., 2011). Therefore, kisspeptin has been found to
increase hypothalamic concentrations of GnRH and plasma concentrations of LH during
the attainment of puberty in multiple mammalian species.
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The expression of hypothalamic Kiss1 is associated with the attainment of
puberty in mammalian species. Navarro et al. (2004) reported that immediately before the
onset of puberty there was a dramatic increase in the expression of hypothalamic Kiss1 in
female and male rats. This same phenomenon has been reported in gonadally intact
female monkeys (Shahab et al., 2005). It was also shown that hypothalamic Kiss1 mRNA
expression was up regulated in ovariectomized (OVX) and intact rats that were
administered E2 compared to OVX and intact rats that received no estradiol-17 (E2) (Cui
et al., 2015). Navarro et al. (2004) showed that there was an increase in hypothalamic
expression of Kiss1 around the time of puberty in male and female rats. Similarly, there
was also an increase in the MBH expression of Kiss1 mRNA during the attainment of
puberty in intact female rhesus monkeys (Shahab et al., 2005). Nestor et al. (2012) also
showed that the number of kisspeptin neurons in the ARC was greater in post-pubertal
ewes versus pre-pubertal lambs. Therefore, it is evident that an increase in hypothalamic
Kiss1 gene expression is correlated with hypothalamic concentrations of kisspeptin and
an increase in the production of GnRH at a time coincident with the attainment of puberty
in mammals.
It is widely accepted that exogenous and endogenous kisspeptin partially control
the LH surge (Lents et al., 2008; Luque et al., 2011). A multitude of research has also
been done demonstrating the effects of the administration of a kisspeptin antagonist and
its effects on the hypothalamo-pituitary-gonadal axis. During ICV infusion of a
kisspeptin antagonist in the ewe there was no pulsatile release of LH detected compared
to controls (Roseweir et al., 2009). Smith et al. (2011) demonstrated that through the
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administration of a Kiss1-receptor antagonist there was a decrease in plasma
concentrations of LH in OVX ewes. Intracerebroventricular infusion of a kisspeptin
antagonist also caused delayed vaginal opening, decreased uterine and ovarian weights,
and prevented the LH and FSH surge in female rats (Pineda et al., 2010). Hence, through
the administration of kisspeptin antagonists, it has been proven that kisspeptin is a pivotal
hormone that causes the release of LH in sheep, rats, and pigs (Lents et al., 2008).
Kisspeptin has been proven essential in puberty through its intimate relationship
with GnRH neurons (Hrabovszky et al., 2007). Measurement of hypothalamic Kiss1
mRNA expression and hypothalamic concentrations of kisspeptin along with other
hormones may provide insight into possible answers regarding kisspeptins exact
association with the attainment of puberty. Previous research has shown that kisspeptin
plays an integral role in the regulation of reproduction, however, changes in the
hypothalamic kisspeptin system and related reproductive hormones during the
peripubertal period in gilts has not been determined. Therefore, the objectives of the
current experiments were to determine 1) plasma concentrations of E2 and P4, 2) AP
concentrations of LH, IGF-I and kisspeptin, and 3) MBH expression of Kiss1 and
concentrations of kisspeptin during the peripubertal period in the gilt.
Materials and Methods
Animals
Two experiments were conducted with twenty five crossbred gilts (Duroc x Large
White x Landrace) in each experiment. On d 1 of both experiments, gilts were received
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and penned (1.83 x 2.44 m) into groups of 3 and 4. Gilts were of similar age (151.5 ± 4.5
d) and weight (104.9 ± 0.3 kg) in both experiments. Gilts were given ad libitum access to
water and a corn-soy based diet that contained 3.4 Mcal ME/kg, 18% protein, and 0.9%
lysine. On day 1 of both experiments gilts were exposed to a mature boar twice daily.
Gilts were exposed to a mature boar for 6 d in the first experiment and 7 d in the second
experiment. Gilts in the first experiment were slaughtered on d 7 and gilts in the second
experiment were slaughtered on d 8. In the first experiment, blood samples (10 mL) were
collected from gilts via jugular venipuncture on d 1 and 3 into sodium heparin tubes. In
the second experiment, blood samples (10 mL) were collected from gilts via jugular
venipuncture on d 2, 4, and 6 into sodium heparin tubes. All samples were collected on
ice, centrifuged (1,500 x g, for 30 min at 4ºC), and frozen within 60 min to prevent
protein degradation.
Estrus detection was performed twice daily at 12 h intervals in both experiments.
The day gilts stood immobile in the presence of the boar was considered the day they
attained puberty (n=8/study). The remaining gilts (n=17/study) that did not stand in estrus
within 24 hours of slaughter were considered to be peripubertal. On d 7 of the first
experiment and d 8 of the second experiment all gilts were slaughtered at the South
Dakota State University Meat Lab when blood, anterior pituitaries (AP), mediobasal
hypothalami (MBH), and reproductive tracts were collected. Anterior pituitary glands and
MBH were trimmed of connective tissue, bisected midsaggitally, wrapped in aluminum
foil, snap frozen in liquid nitrogen, and stored at -80ºC. Following slaughter, reproductive
tracts were subjectively evaluated for edema and tone and ovaries were evaluated for
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structures including follicles, corpora hemmorhagica, corpora lutea, and corpora
albicantia to determine if gilts had cycled prior to the experiment. All experimental
procedures were reviewed and approved by the Institutional Animal Care and Use
Committee at South Dakota State University.
Estradiol-17
For both experiments plasma concentrations of E2 were determined in duplicate
by RIA in the same assay. Estradiol-17 (E8875; Sigma Life Science, St. Louis, MO)
was the standard and radioiodinated E2 (#07138228; MP Biomedicals, Solon, OH) was
the tracer. Antisera (GDN#244 anti-estradiol-17-6-BSA; Fort Collins, CO) was used at
a dilution of 1:425,000. Sera (250-L) were extracted with a 4-mL volume of methyl tertbutyl ether. Recovery of [125I]estradiol-17 added to porcine plasma before extraction
averaged 94.6 ± 2.5%. Inhibition curves of increasing amounts of sample were parallel to
standard curves. Intra-assay and inter-assay coefficients of variation were 11.4% and
15.7%, respectively. Sensitivity of the assay was 0.5 pg/tube.
Insulin-Like Growth Factor I
Anterior pituitary gland concentrations of IGF-I were determined in duplicate by
RIA (Echternkamp et al., 1990; Funston et al., 1995). One half of each anterior pituitary
gland was homogenized in a 15-mL polypropylene tube with 2-mL of homogenization
buffer (1% cholic acid, 0.1% SDS, 200 M phenylmethylsulfonylfluoride, 100 M
EDTA, 1 M leupeptin, and 1 M pepstatin) and homogenized on ice with a T25 UltraTurrax tissue dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. Anterior
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pituitary glands were then diluted to 100 mg of AP tissue/mL with homogenization
buffer. Homogenates were centrifuged at 12,000 x g for 10 min at 4ºC and the
supernatant was removed and stored at -20ºC. Protein content of the AP homogenates
(1:20 dilution) was determined by the Bradford method using reagents provided by BioRad (Hercules, CA). Insulin-like growth factor binding proteins were extracted from all
homogenized anterior pituitary gland samples with a 1:17 ratio of sample to acidified
ethanol (12.5% 2 N HCl:87.5% absolute ethanol; (Daughaday et al., 1980)). Recombinant
human IGF-I (GF-050; Austral Biological, San Ramon, CA) was used as the standard and
radioiodinated antigen. Antisera (UB2-495; National Hormone and Peptide Program,
NIDDK) was used at a dilution of 1:62,500. Recovery of [125I]IGF-I added to porcine
serum before extraction averaged 83 ± 1.5%. Inhibition curves of increasing amounts of
sample were parallel to standard curves. Intra-assay coefficient of variation in the first
experiment was 14.8%. Intra-assay and inter-assay coefficients of variation in the second
experiment were 3.2% and 7.9%, respectively. Sensitivity of the assay for both
experiments was 11.9 pg/tube.
Luteinizing Hormone
Anterior pituitary gland concentrations of LH were determined in triplicate by
RIA (Clapper et al., 1998). Porcine LH (AFP3881A; National Hormone and Peptide
Program, NIDDK) was used as the radioiodinated antigen and standard. Luteinizing
hormone antiserum (AFP15103194; National Hormone and Peptide Program, NIDDK)
was used at a dilution of 1:200,000. Anterior pituitary homogenates were diluted
1:25,000 in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing
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amounts of sample were parallel to standard curves. Intra-assay coefficient of variation in
the first experiment was less than 1%. Intra-assay and inter-assay coefficients of variation
in the second experiment were 16.5% and 15.8%, respectively. Sensitivity of the assay
for both experiments was 0.10 ng/tube.
Kisspeptin-54
Hypothalamic and AP concentrations of kisspeptin-54 were determined in
duplicate by RIA. Human kisspeptin (1443; Tocris Bioscience, Ellsville, MO) was used
as the radioiodinated antigen and standard. Kisspeptin antiserum (GQ2; provided by
Waljit Dhillo, Imperial College, London, England, UK) was used at a dilution of
1:50,000. The GQ2 kisspeptin antibody cross reacted 100% with human kisspeptin-54,
kisspeptin-14, and kisspeptin-10 and less than 0.01% with any other related human RF
amide protein (Dhillo et al., 2005). Hypothalami and AP homogenates were diluted 1:30
in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing amounts of
sample were parallel to standard curves. Intra-assay coefficients of variation for MBH
and AP assays for the first experiment were 4.6% and 8.0%, respectively. Intra-assay
coefficient of variation for all samples of the second experiment was 7.2%. Sensitivity of
the assay for both experiments was 10.1 pg/tube.
Isolation of RNA
Total RNA was isolated from one half of each AP and MBH using TriReagent
(TR118; Molecular Research Company, Cincinnati, OH). Tissue was homogenized in a
15-mL polypropylene tube containing 1-mL of TriReagent with a T25 Ultra-Turrax tissue
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dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. After homogenization
the resulting homogenates were diluted to 5-mL with TriReagent. One milliliter of the
resulting homogenate was removed from the 15-mL polypropylene tube and pipetted into
a 1.5-mL polypropylene tube. One hundred microliters of 1-bromo-3-chloropropane
(BCP; #BP151, Molecular Research Center, Cincinnati, OH) was added to the
polypropylene Eppendorf tubes containing 1-mL of homogenate, mixed, and incubated at
room temperature for 5 min. Samples were centrifuged (12,000 x g for 15 min at 4ºC)
and the resulting aqueous layer was removed. Isopropanol (500 L) was added to the
aqueous layer to precipitate the RNA. The resulting RNA pellet was washed twice with
75% ethanol, centrifuged, dried, and suspended in nuclease-free water. Concentration of
RNA was determined via spectrophotometer (Nanodrop, Thermo Scientific, Washington,
DE). Purity of RNA was determined by measuring the A260/A280 ratio. The ratio of all
samples ranged from 1.8 to 2.0.
cDNA Synthesis
Any contaminating DNA was removed from 10 g of AP RNA and 5 g of MBH
RNA for each sample using the Turbo DNA-Free™ Kit (#AM1907; Ambion, Austin,
TX) following the manufacturer’s protocol. Two g of the resulting RNA was reverse
transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit
containing random hexamer primers (#4374966; Applied Biosystems, Foster City, CA)
following the manufacturer’s protocol.
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Porcine Primers
Previously published mRNA sequences for the gene of interest, porcine -actin,
was used to design specific forward and reverse primers. Primers were designed using
software provided by Integrated DNA Technologies (IDT, Coralville, IA; Table 3.1).
Real-Time PCR
Real-time semi-quantitative PCR was used to measure the quantity of MBH Kiss1
and Kiss1R and AP LH- and gonadotropin releasing hormone receptor (GnRHr) mRNA
relative to the amount of -actin mRNA in each sample. Measurements of the relative
quantity of the cDNA of interest was carried out using RT2 Real-Time™ SYBR
Green/ROX PCR Master Mix (SuperArray Bioscience Corp., Foster City, CA). Twentyfive microliter reactions were measured using the Stratagene MX3005P quantitative realtime PCR instrument (Agilent Technologies, Foster City, CA). Thermal cycling
conditions recommended by the manufacturer (40 cycles of 30 sec at 95ºC, 1 min at
55ºC, and 1 min at 72ºC) were used for all except Kiss1, in which the following thermal
cycling conditions were used; 45 cycles of 30 sec at 95ºC, 1 min and 3 sec at 55ºC, and 1
min at 72ºC. Concentrations of forward and reverse primers used for the genes of interest
were 300 nM, except Kiss1R, in which concentrations of forward and reverse primers
were used at a concentration of 800 nM. A linear response was obtained when these
concentrations of primer pairs were used with increasing amounts of cDNA. Dissociation
curve analysis was performed after each real-time PCR run to confirm that a single
amplicon of appropriate melting temperature was present. Additionally, all amplicons
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were electrophoresed through a 2% agarose gel and stained with ethidium bromide to
visualize that only amplicons of the appropriate size were present in each sample.

Table 3.1.
Forward and reverse primers for Real-Time PCR for porcine mRNA
Gene and
Accession Number

Primer

Amplicon Size

pKiss1
(NM_001134964.1)a

Forward
Reverse

89 bp
5’ – GGCAGCTGATGTTCTTTCTTTG – 3’
5’ – CGGGCCTGTAGATCTAGGATT – 3’

pLH-
(NM_214080.1)c

Forward
Reverse

151 bp
5’ – ATGCTCCAGAGACTGCTGTTGT – 3’
5’ – TGCTGGTGGTAAAGGTGATGCAGA – 3'

GnRHR
(NM_214273.1)d

Forward
Reverse
p-actin
(U07786.1)e
Forward
Reverse
a

101 bp
5’ – AGCCAACCTGTTGGAGACTCTGAT – 3’
5’ – AGCTGAGGACTTTGCAGAGGAACT – 3'

129 bp
5’ – TCGCCGACAGGATGCAGAAGGA – 3’
5’ – AGGTGGACAGCGAGGCCAGGAT – 3’

porcine Kiss1; b porcine Kiss type 1 receptor; c porcine luteinizing hormone subunit beta; d
porcine gonadotropin releasing hormone receptor; e porcine beta-actin
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Statistical Analysis
The same statistical analyses were used in both experiments. To determine the
effect of day on plasma concentrations of estradiol-17, hypothalamic concentrations of
kisspeptin-54 and anterior pituitary concentrations of kisspeptin-54, IGF-I, and LH,
statistical analyses were performed using the GLIMMIX Procedure of SAS 9.3 (SAS 9.3,
SAS) to compare pubertal and peripubertal gilts. The model for determining differences
in estradiol-17 was Yijkl =  + Pigi + Pubertal Statusj + Pigi(Pubertal Status)j + Dayk +
Pubertal Statusj x Dayk +Pigi(Pubertal Status)j x Dayk + eijkl with repeated measures. Pig
within treatment by day was the subplot error term used to test pig, day, and pubertal
status by day effects. The model for determining hypothalamic concentrations of
kisspeptin and anterior pituitary concentrations of kisspeptin, IGF-I, and LH was Yijk = 
+ Pigi + Pubertal Statusj + Pigi(Pubertal Status)j + eijk. Pig within pubertal status was the
whole plot error term used to test the effect of treatment.
Fold differences in expression of MBH Kiss1 and Kiss1R and AP LH- and
GnRHR among treatments were determined using the Relative Expression Software Tool
(REST; Corbett Research and M. Pfaffl, Technical University Munich). The expression
of a target gene is standardized by a non-regulated gene. Relative expression is based on
the expression ratio of a target gene versus a reference gene. The expression ratio results
of the investigated transcripts were tested for significance by Pair Wise Fixed
Reallocation Randomized Test (Pfaffl et al., 2002).
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Results – Experiment 1
To confirm that gilts had not cycled before both experiments, ovaries were
examined post-slaughter and no corpora lutea, corpora albicantia, or corpora
hemmorhagica were found.
Mean plasma concentrations of E2 were not different (P>0.05) in pubertal versus
peripubertal gilts on d 1 and 3 of the experiment and were greater (P<0.05) within both
groups of gilts comparing d 1 to 3 of the experiment (Figure 3.1). Mean plasma
concentrations of E2 were greater (P=0.02) in pubertal versus peripubertal gilts on d 7 of
the experiment (Figure 3.1).
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Day of Experiment
Figure 3.1. Mean plasma concentrations of estradiol-17 in gilts that had (n=8) and had
not (n=17) attained puberty. Data are expressed as least square means ± SEM. abcMeans
with different letters differ (P<0.05) according to pubertal status and/or day.
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No differences were detected (P>0.05) in mean AP concentrations of IGF-I in
pubertal versus peripubertal gilts (Figure 3.2).

AP IGF-I
30

IGF-I, ng/mg

25
20
15
10
5
0
Peripubertal

Pubertal

Pubertal Status

Figure 3.2. Mean AP concentrations of IGF-I in gilts that had (n=8) and had not (n=17)
attained puberty. Data are expressed as least-square means ± SEM.
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No differences were detected (P>0.05) in mean AP concentrations of LH in
pubertal versus peripubertal gilts (Figure 3.3).
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Figure 3.3. Mean AP concentrations of LH in gilts that had (n=8) and had not (n=17)
attained puberty. Data are expressed as least-square means ± SEM.
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Mean MBH concentrations of kisspeptin were greater (P=0.04) in pubertal gilts
compared to peripubertal gilts (Figure 3.4).
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Figure 3.4. Mean hypothalamic concentrations of kisspeptin in gilts that had (n=8) and
had not (n=17) attained puberty. Data are expressed as least-square means ± SEM.
ab
Means with different letters differ (P=0.04) by group.
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Mean relative expression of MBH Kiss1 was up-regulated (P=0.005)
approximately 2-fold in pubertal gilts compared to peripubertal gilts (Figure 3.5).
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Figure 3.5. Mean relative expression of hypothalamic Kiss1 in gilts that had (n=8) and
had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the level
of Kiss1 by quantitative reverse transcriptase real time PCR with normalization for the
corresponding level of -actin. Data are expressed as a fold change in expression relative
to the pigs that had not attained puberty. abMeans with different letters differ (P=0.005) as
determined by relative expression software tool.
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No differences were detected (P>0.05) in mean AP concentrations of kisspeptin in
pubertal versus peripubertal gilts (Figure 3.6).
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Figure 3.6. Mean anterior pituitary concentrations of kisspeptin in gilts that had (n=8)
and had not (n=17) attained puberty. Data are expressed as least-square means ± SEM.
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Mean relative expression of AP LH- did not differ (P>0.05) in pubertal versus
peripubertal gilts (Figure 3.7).
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Figure 3.7. Mean relative expression of anterior pituitary LH- in gilts that had (n=8)
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the
level of LH- by quantitative reverse transcriptase real time PCR with normalization for
the corresponding level of -actin. Data are expressed as a fold change in expression
relative to the pigs that had not attained puberty.
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Mean relative expression of AP GnRHR did not differ (P>0.05) in pubertal versus
peripubertal gilts (Figure 3.8).
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Figure 3.8. Mean relative expression of anterior pituitary GnRHR in gilts that had (n=8)
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the
level of GnRHR by quantitative reverse transcriptase real time PCR with normalization
for the corresponding level of beta-actin. Data are expressed as a fold change in
expression relative to the pigs that had not attained puberty.
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Results – Experiment 2
Mean plasma concentrations of E2 were not different (P>0.10) in pubertal versus
peripubertal gilts on d 2, 4, and 8 of the experiment (Figure 3.9). Mean plasma
concentrations of E2 tended to be greater (P=0.06) on d 4 and were greater (P=0.02) on d
6 in pubertal versus peripubertal animals (Figure 3.9).
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Figure 3.9. Mean plasma concentrations of estradiol-17 in gilts that had (n=8) and had
not (n=17) attained puberty. Data are expressed as least square means ± SEM. abMeans
with different letters differ (P<0.05) according to pubertal status and/or day.
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No differences were detected (P>0.05) in mean AP concentrations of IGF-I in
pubertal versus peripubertal gilts (Figure 3.10).
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Figure 3.10. Mean AP concentrations of IGF-I in gilts that had (n=8) and had not (n=17)
attained puberty. Data are expressed as least-square means ± SEM.
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Mean AP concentration of LH were less (P=0.01) in pubertal versus peripubertal
gilts (Figure 3.11).
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Figure 3.11. Mean AP concentrations of LH in gilts that had (n=8) and had not (n=17)
attained puberty. Data are expressed as least-square means ± SEM. abMeans with
different letters differ (P=0.01) by group.
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No differences were detected (P>0.05) in mean MBH concentrations of kisspeptin
in pubertal versus peripubertal gilts (Figure 3.12).
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Figure 3.12. Mean hypothalamic concentrations of kisspeptin in gilts that had (n=8) and
had not (n=17) attained puberty. Data are expressed as least-square means ± SEM.
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Mean relative expression of MBH Kiss1 did not differ (P>0.05) in pubertal versus
peripubertal gilts (Figure 3.13).
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Figure 3.13. Mean relative expression of hypothalamic Kiss1 in gilts that had (n=8) and
had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the level
of Kiss1 by quantitative reverse transcriptase real time PCR with normalization for the
corresponding level of -actin. Data are expressed as a fold change in expression relative
to the pigs that had not attained puberty.
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Mean AP concentrations of kisspeptin-54 were greater (P=0.04) in pubertal versus
peripubertal gilts (Figure 3.14).
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Figure 3.14. Mean anterior pituitary concentrations of kisspeptin in gilts that had (n=8)
and had not (n=17) attained puberty. Data are expressed as least-square means ± SEM.
ab
Means with different letters differ (P=0.04) by group.
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Mean relative expression of AP LH- did not differ (P>0.05) in pubertal versus
peripubertal gilts (Figure 3.15).
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Figure 3.15. Mean relative expression of anterior pituitary LH- in gilts that had (n=8)
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the
level of LH- by quantitative reverse transcriptase real time PCR with normalization for
the corresponding level of -actin. Data are expressed as a fold change in expression
relative to the pigs that had not attained puberty.
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Mean relative expression of AP GnRHR did not differ (P>0.05) in pubertal versus
peripubertal gilts (Figure 3.16).
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Figure 3.16. Mean relative expression of anterior pituitary GnRHR in gilts that had (n=8)
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the
level of GnRHR by quantitative reverse transcriptase real time PCR with normalization
for the corresponding level of beta-actin. Data are expressed as a fold change in
expression relative to the pigs that had not attained puberty.
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Discussion
Plasma concentrations of E2 increase as animals approach puberty, which occurs
at a time around standing estrus. This increase in E2 causes the preovulatory GnRH and
LH surge. Gonadotropin releasing hormone neurons are scattered throughout the
hypothalamus and are considered to be the gatekeepers for the attainment of puberty,
however, new research indicates there may be several factors controlling the attainment
of puberty, including kisspeptin (Silverman et al., 1987; Silverman et al., 1979). Because
research is equivocal as to whether GnRH neurons possess estrogen receptors it is
thought that other factors contribute to the attainment of puberty.
Kisspeptin is a neurohormone that is produced by the Kiss1 gene (Kotani et al.,
2001). Kisspeptin and kisspeptin neurons have been demonstrated to associate intimately
with GnRH neurons in the hypothalamus (Hrabovszky et al., 2007). It was reported that
deletions or mutations in GPR54 in the mouse resulted in infertility and the failure to
attain puberty (de Roux et al., 2003; Seminara et al., 2003). Additionally, deletions and
mutations in the Kiss1 gene in humans and mice have been associated with difficulties in
the attainment of puberty (d'Anglemont de Tassigny et al., 2007; Lapatto et al., 2007).
These data support the notion that the hypothalamic kisspeptin system is associated with
the attainment of puberty in multiple mammalian species.
Plasma concentrations of estradiol-17 have been demonstrated to be increased
during the attainment of puberty in gilts (Karlbom et al., 1982). In the present studies,
plasma concentrations of E2 were the same among all animals upon their arrival in both
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experiments. By the end of experiment 1, gilts that were considered to be pubertal by
exhibiting a standing estrus response had greater plasma concentrations of E2 than gilts
that were considered peripubertal. Gilts in experiment 2 were slaughtered a day later,
however, there was no difference in plasma concentrations of E2, but plasma
concentrations of E2 were greater on d 6 (2 days prior) in gilts that had attained puberty
versus gilts that were peripubertal. It is worth noting that this difference in plasma
concentrations of E2 may influence MBH and AP concentrations of hormones comparing
the puberty experiments. Therefore, it is apparent that the timing of sample collection and
which day gilts are slaughtered greatly affected plasma concentrations of E2.
In both experiments there was no difference in AP concentrations of IGF-I in gilts
that pubertal compared to gilts that were peripubertal. Clapper and Taylor (2011)
demonstrated that on d 19 of the estrous cycle AP concentrations of IGF-I were greater
than on d 7, 13, or 22 of the estrous cycle. Insulin-like growth factor I has also been
shown to have positive effects on the LH surge in a number of species (Adam et al.,
2000; Stewart et al., 1996). In addition to its effects on LH, IGF-I has also been shown to
induce an increase in hypothalamic expression of Kiss1 mRNA during the onset of
puberty in rats (Hiney et al., 2009). Hiney et al. (2009) also demonstrated that when rats
were administered an IGF-I inhibitor there was a decrease in hypothalamic Kiss1 mRNA
expression in the rat. Therefore, it is plausible that IGF-I may influence hypothalamic
concentrations of kisspeptin and expression of Kiss1 mRNA, however, the exact
mechanism has not been determined. Previous research has indicated that the effects of
IGF-I are modulated by insulin-like growth factor binding proteins (IGFBP) (Bourner et
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al., 1992; Ling et al., 1993). Insulin-like growth factor binding proteins can have either
inhibitory or stimulatory effects (Mohan and Baylink, 2002), which can also be tissue
specific (Hoeflich et al., 2000; Slootweg et al., 1995). Additionally, direct actions of
IGFBP that are independent of IGF-I may exist (Andress, 1998). It is plausible that
IGFBP may contribute in the regulation of the hypothalamic kisspeptin system, however
they were not quantified in the present experiments.
Puberty in the gilt can be defined as the first time the gilt expresses a standing
estrus. It is widely accepted during the attainment of puberty the preovulatory LH surge
occurs followed by ovulation approximately 24-36 h later (Driancourt et al., 2013).
Although the LH surge was not measured in this experiment it occurs during the time
before a standing estrus in the gilt. In the first experiment there was no difference in AP
concentrations of LH in pubertal versus peripubertal gilts. However, in the second
puberty experiment there were decreased AP concentrations of LH in gilts that had
attained puberty versus peripubertal gilts. Comparing this with MBH and AP
concentrations of kisspeptin and hypothalamic Kiss1 mRNA expression, there is an
apparent difference in hormone levels when gilts are slaughtered one day later with
respect to the start of boar exposure. In the first experiment both hypothalamic Kiss1
mRNA expression and MBH concentrations of kisspeptin were greater in gilts that had
attained puberty compared to peripubertal gilts. In the second puberty experiment there
were no differences in hypothalamic Kiss1 mRNA expression and MBH concentrations
of kisspeptin comparing pubertal and peripubertal gilts. During the attainment of puberty
there is an increase in hypothalamic Kiss1 mRNA expression in rodents and sheep
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(Navarro et al., 2004; Shahab et al., 2005), which correlates with the first puberty
experiment. Although the second experiment does not correlate with previous research,
we think it is due to timing of sample collection.
There was no difference in AP concentrations of kisspeptin between pubertal and
peripubertal gilts in the first experiment, however AP concentrations of kisspeptin were
greater in gilts that were pubertal compared to gilts that were peripubertal in the second
study. When gilts were slaughtered a day later there was a decrease in AP concentrations
of LH in pubertal gilts versus peripubertal gilts as well as an increase in AP
concentrations of kisspeptin. Navarro et al. (2004) demonstrated that central
administrations of kisspeptin increased plasma concentrations of LH in female rats
compared to controls. Also, repetitive administration of kisspeptin to prepubertal female
lambs increased plasma concentrations of sex steroids as well as caused the preovulatory
LH surge (Redmond et al., 2011). In experiment 1 there was an increase in plasma
concentrations of E2 in pubertal gilts versus peripubertal gilts on the day gilts were
slaughtered. On the same day, there was also an increase in hypothalamic concentrations
of kisspeptin and MBH expression of Kiss1, however, there was no difference in AP
concentrations of kisspeptin and LH comparing pubertal to peripubertal gilts.
In experiment 2 there was no difference in plasma concentrations of E2 between
treatments on the day gilts were slaughtered (d 8), however, plasma concentrations of E2
were greater on d 6 in pubertal animals. Additionally, there was no difference in
hypothalamic concentrations of kisspeptin and expression of Kiss1 between treatments,
however, there was an increase in AP concentrations of kisspeptin and a decrease in
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concentrations of LH in pubertal gilts in the second study. A plausible mechanism could
be that hypothalamic expression of Kiss1 is increasing at a time temporally related with
an increase in release of AP LH (Lents et al., 2008; Sebert et al., 2010; Whitlock et al.,
2008). At a time coincident with an increase in hypothalamic expression of Kiss1 there
was an increase in hypothalamic concentrations of kisspeptin in the present study.
Kisspeptin receptor expression and kisspeptin receptors have been found to be coexpressed with GnRH neurons in the hypothalamus and in the AP (Hrabovszky et al.,
2007; Irwig et al., 2004; Li et al., 2012). Additionally, peripheral administration of
kisspeptin-54 has been shown to activate GnRH neurons in the hypothalamus (Caraty et
al., 2007). Therefore, an increase in MBH and/or AP concentrations of kisspeptin may
increase kisspeptin receptor binding in the MBH and/or AP potentially causing the
increased release of GnRH and/or LH, respectively. Although the exact mechanism of the
interaction of AP LH and MBH and AP kisspeptin in the pig is not fully understood,
these data indicate the existence of this possible mechanism.
Although no differences were found in AP expression of LH- and GnRHR
mRNA between treatments in the present studies, it is plausible that during the attainment
of puberty, which is coupled with an increase in peripheral concentrations of E2, there is
an up-regulation of AP expression of LH- and GnRHR. During the time of the
preovulatory LH surge AP LH- and GnRHR mRNA expression are up-regulated in the
rat (Haisenleder et al., 1988; Seong et al., 1998). Luteinizing hormone subunit-beta
confers the biological activity of LH and at times during the preovulatory LH surge AP
LH- mRNA expression is up regulated nearly 3-fold in the rat (Haisenleder et al., 1988).
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Under the influence of both progesterone and estrogen, rats exhibited an increase in AP
expression of GnRHR mRNA compared to rats that were only under the influence of
estrogen (Seong et al., 1998). Turzillo et al. (1994) found that E2 caused an increase in
AP expression of GnRHR mRNA in the ewe. Although no differences in AP expression
of GnRHR and LH- were found in the present experiments, we believe that the timing
of sample collection and/or species differences may have impacted our results.
Haisenleder et al. (1988) found differences in the rat, however, our timing was not as
precise as theirs due the rat having a shorter estrous cycle.
Timing is critical in detecting differences in hormone concentrations that occur
during the peripubertal period. Following relocation and boar exposure, which caused
gilts to attain puberty, there were differences in MBH and AP concentrations of
kisspeptin and Kiss1 mRNA expression in gilts slaughtered 7 days versus gilts
slaughtered 8 days following the start of boar exposure. Although there were variations in
hypothalamic, anterior pituitary, and peripheral levels of hormones in the present studies
due to timing, changes within the hypothalamic kisspeptin system are consistent with
what is found in other mammalian species.
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Chapter 4
Summary and Conclusions
The results of these experiments provide evidence that MBH and AP
concentrations of kisspeptin and Kiss1 mRNA expression differ throughout the estrous
cycle and during the peripubertal period. The levels of MBH, AP, and plasma hormones
seemed to be equivocal comparing both of the puberty experiments. Timing of sample
collection is important when measuring tissue hormone levels throughout the estrous
cycle and during the attainment of puberty. It is plausible that kisspeptin may be a driving
factor in the GnRH and LH surge, which is a time temporally related with a standing
estrus.
During the estrous cycle there were increased levels of AP LH on d 14 versus d
21 of the estrous cycle, indicating that the AP released LH between those times and the
preovulatory LH surge had occurred. At a time temporally related with the released of AP
LH, hypothalamic Kiss1 mRNA expression was 2.5-fold greater versus when AP
concentrations of LH were increased. Relative expression of MBH ER- mRNA was also
down regulated at a time coincident with increased MBH Kiss1 mRNA expression and a
standing estrus. This decrease in expression may have been caused by kisspeptin or other
reproductive hormones during a standing estrus, which is temporally related with the
preovulatory LH surge.
During the first experiment of the puberty study gilts were slaughtered on d 7 and
there was increased hypothalamic expression of Kiss1 and increased MBH concentrations
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of kisspeptin in pubertal versus peripubertal gilts. This occurred during the time when
gilts stood in estrus; a time temporally related with the preovulatory LH surge. During the
second experiment of the puberty study gilts were slaughtered on d 8 and there were no
differences in hypothalamic Kiss1 expression and MBH concentrations of kisspeptin
between treatments, however, AP concentrations of kisspeptin were greater in pubertal
gilts compared to peripubertal gilts. Pubertal gilts also had decreased AP concentrations
of LH versus peripubertal gilts. This indicates that an increase in AP concentrations of
kisspeptin and a decrease in AP concentrations of LH occur at a time coincident with
each other and during a standing estrus. It is plausible that this occurred because
kisspeptin was released from the hypothalamus into the hypothalamo-pituitary portal
plexus, traveled to the AP, and in concert with GnRH, caused the release of LH.
Therefore, these studies agree with previous research and support the notion that
during the time of a standing estrus and the expected preovulatory LH surge, there was an
increase in hypothalamic Kiss1 expression and/or an increase in MBH and/or AP
concentrations of kisspeptin.
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